( (CODE <begin_rr166>))

( (NP (NN Introduction)))

( (S (NP-SBJ (NP (DT The) (NN concept))
	     (PP (IN of)
		 (NP (NP (NN lung) (NNS fibroblasts))
		     (PP (IN as)
			 (NP (NP (NN effector) (NNS cells))
			     (PP (IN in)
				 (NP (NP (DT the) (NN pathogenesis))
				     (PP (IN of)
					 (NP (JJ idiopathic) (JJ pulmonary) (NN fibrosis)
					     (CODE -LRB-)
					     (PRN (NP (NNP IPF))))))))))))
     (CODE -RRB-)
     (VP (VBZ has)
	 (ADVP-TMP (RB recently))
	 (VP (VBN evolved)))
     (CODE <bracket>)
     (CODE {footnote_indexicals_omitted})
     (CODE <$$bracket>)
     (. .)))

( (S (NP-SBJ (NN Lung) (NNS fibroblasts))
     (VP (VBP respond)
	 (, ,)
	 (NP-LOC (FW in) (FW vitro))
	 (, ,)
	 (PP (IN to)
	     (NP (JJ inflammatory) (NNS cytokines)))
	 (PP-MNR (IN by)
		 (S-NOM (NP-SBJ (-NONE- *PRO*))
			(VP (VBG producing)
			    (NP (NP (NN growth) (NNS factors))
				(CC and)
				(NP (NN collagen))))))
	 (, ,)
	 (S-ADV (NP-SBJ (-NONE- *PRO*))
		(VP (VBG resulting)
		    (PP-CLR (IN in)
			    (NP (NP (NN fibroblast) (NN proliferation))
				(CC and)
				(NP (NML (JJ extracellular) (NN matrix))
				    (NN deposition)))))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (S (PP (IN In)
	    (NP (NN addition)))
	(, ,)
	(NP-SBJ-1 (VBN activated) (NN lung) (NNS fibroblasts))
	(VP (VBP have)
	    (VP (VBN been)
		(VP (VBN shown)
		    (S (NP-SBJ (-NONE- *-1))
		       (VP (TO to)
			   (VP (VB produce)
			       (NP (NP (JJ large) (NNS amounts))
				   (PP (IN of)
				       (NP (JJ inflammatory) (NNS cytokines) (CC and) (NNS chemokines))))
			       (, ,)
			       (NP-LOC (FW in) (FW vitro)))))))))
     (, ,)
     (CC and)
     (S (ADVP (RB hence))
	(, ,)
	(NP-SBJ (DT these) (NNS cells))
	(VP (MD may)
	    (ADVP (RB also))
	    (VP (VB have)
		(NP (DT a) (NN role))
		(PP (IN as)
		    (NP (NML (NN effector) (HYPH -) (JJ inflammatory))
			(NNS cells))))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (NP-SBJ (NP (DT This) (NN capacity))
	     (S (NP-SBJ (-NONE- *PRO*))
		(VP (TO to)
		    (VP (VB produce)
			(NP (ADJP (CC both) (JJ inflammatory) (CC and) (JJ fibrotic))
			    (NNS factors))))))
     (VP (MD could)
	 (VP (VB mean)
	     (SBAR (IN that)
		   (S (NP-SBJ (ADJP (RB phenotypically) (VBN altered))
			      (NN lung)
			      (NNS fibroblasts))
		      (VP (VBP act)
			  (ADVP-TMP (RB simultaneously))
			  (PP-CLR (IN as)
				  (NP (NML (NN effector) (CC and) (NN target))
				      (NNS cells)))
			  (, ,)
			  (PP-MNR (IN via)
				  (NP (ADJP (JJ paracrine) (CC and) (JJ autocrine))
				      (NNS mechanisms)))
			  (, ,)
			  (S-ADV (NP-SBJ (-NONE- *PRO*))
				 (VP (VBG perpetuating)
				     (NP (DT the) (JJ fibrotic) (NN process)))))))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (NP-SBJ (NNS Prostanoids))
     (VP (VBP are)
	 (NP-PRD (NP (JJ important) (NNS regulators))
		 (PP (IN of)
		     (NP (NN fibroblast)
			 (NN function)
			 (QP (CODE <bracket>) (CD 5) (CD 6) (CD 7) (CD 8) (CD 9))))))
     (CODE <$$bracket>)
     (. .)))

( (S (NP-SBJ-1 (NN Prostaglandin)
	       (CODE -LRB-)
	       (PRN (NP (NN PG)))
	       (CODE -RRB-)
	       (NN E)
	       (CD 2))
     (VP (VP (VBZ is)
	     (VP (VBN thought)
		 (S (NP-SBJ (-NONE- *-1))
		    (VP (TO to)
			(VP (VB have)
			    (NP (JJ antifibrotic) (NNS properties))
			    (NP-LOC (FW in) (FW vitro)))))))
	 (, ,)
	 (CONJP (CC but) (RB also))
	 (VP (MD can)
	     (VP (VB have)
		 (NP (JJ proinflammatory) (NNS effects))
		 (NP-LOC (CC both)
			 (NP (FW in) (FW vivo))
			 (CC and)
			 (NP (FW in) (FW vitro))))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (NP-SBJ (NN Thromboxane)
	     (CODE -LRB-)
	     (PRN (NP (NN TX)))
	     (CODE -RRB-)
	     (NN A)
	     (CD 2))
     (VP (VBZ increases)
	 (NP (NP (NN proliferation))
	     (, ,)
	     (CC and)
	     (NP (NML (NN DNA) (CC and) (NN RNA))
		 (NN synthesis)))
	 (PP (IN in)
	     (NP (NP (JJ several) (NN cell) (NNS types))
		 (, ,)
		 (PP (VBG including)
		     (NP (NP (NNS fibroblasts))
			 (CC and)
			 (NP (NP (JJ smooth) (NN muscle))
			     (PP (IN like)
				 (NP (JJ glomerular) (JJ mesangial) (NNS cells)))))))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (ADVP (RB Conversely))
     (, ,)
     (NP-SBJ (NN prostacyclin) (CODE -LRB-) (NN PGI) (CD 2))
     (CODE -RRB-)
     (VP (VBZ decreases)
	 (NP (NP (NML (NML (JJ smooth) (NN muscle))
		      (NN cell))
		 (NN proliferation))
	     (CC and)
	     (NP (NN collagen) (NN synthesis))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (NP-SBJ (NP (JJ Many) (NN cell) (NNS types))
	     (, ,)
	     (PP (VBG including)
		 (NP (NN lung) (NNS fibroblasts))))
     (, ,)
     (VP (VP (VBP contain)
	     (NP (NP (NN cyclooxygenase)
		     (CODE -LRB-)
		     (PRN (NP (NN COX))))
		 (CODE -RRB-)
		 (, ,)
		 (NP (NP (DT a) (JJ proximal) (NN enzyme))
		     (PP (IN in)
			 (NP (JJ prostanoid) (NN production))))))
	 (, ,)
	 (CC and)
	 (VP (MD can)
	     (VP (VB generate)
		 (NP (NNS prostanoids)))))
     (CODE {COM:footnote_indexical_omitted})
     (. .)))

( (S (NP-SBJ (NP (PRP It))
	     (SBAR (-NONE- *EXP*-1)))
     (VP (VBZ has)
	 (VP (VBN been)
	     (ADVP-TMP (RB previously))
	     (VP (VBN reported)
		 (SBAR-1 (IN that)
			 (S (NP-SBJ-2 (NNP IPF) (NN lung) (NNS fibroblasts))
			    (VP (VP (VBP have)
				    (NP (VBN decreased) (NN COX-2) (NN expression))
				    (S-ADV (NP-SBJ-3 (-NONE- *PRO*-2))
					   (VP (VBN compared)
					       (NP (-NONE- *-3))
					       (PP-CLR (IN to)
						       (NP (JJ normal) (NN lung) (NNS fibroblasts))))))
				(CC and)
				(, ,)
				(ADVP (RB hence))
				(, ,)
				(VP (VBP have)
				    (NP (VBN decreased)
					(NML (NN PGE) (CD 2))
					(NN production)))))))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (PP-PRP (IN Because)
	     (IN of)
	     (NP (NP (DT these) (NNS findings))
		 (CC and)
		 (NP (NP (DT the) (NN fact))
		     (SBAR (IN that)
			   (S (NP-SBJ (NNS PGs))
			      (VP (VBP are)
				  (NP-PRD (JJ important) (NN fibroblast) (NNS regulators))))))))
     (, ,)
     (NP-SBJ-1 (PRP we))
     (VP (VBD sought)
	 (S (NP-SBJ (-NONE- *PRO*-1))
	    (VP (TO to)
		(VP (VB investigate)
		    (SBAR (IN whether)
			  (S (NP-SBJ-2 (NP (NNS abnormalities))
				       (PP (IN in)
					   (NP (NN COX-2) (NN expression))))
			     (VP (MD could)
				 (VP (VB be)
				     (VP (VBN associated)
					 (NP (-NONE- *-2))
					 (PP-CLR (IN with)
						 (NP (NP (DT an) (VBN altered) (NN balance))
						     (PP (IN between)
							 (NP (ADJP (JJ profibrotic) (CC and) (JJ antifibrotic))
							     (NNS PGs))))))))))))))
     (. .)))

( (S (NP-SBJ (PRP We))
     (VP (VBD hypothesized)
	 (SBAR (IN that)
	       (S (NP-SBJ-1 (NP (NNS fibroblasts))
			    (PP (IN from)
				(NP (NP (DT the) (NNS lungs))
				    (PP (IN of)
					(NP (NP (NNS patients))
					    (PP (IN with)
						(NP (NN IPF)
						    (CODE -LRB-)
						    (PRN (NP (NN HF-IPF))))))))))
		  (CODE -RRB-)
		  (VP (VBP have)
		      (NP (DT an) (VBN altered) (NN PG) (NN balance))
		      (S-ADV (NP-SBJ-2 (-NONE- *PRO*-1))
			     (VP (VBN compared)
				 (NP (-NONE- *-2))
				 (PP-CLR (IN to)
					 (NP (JJ normal)
					     (NN lung)
					     (NNS fibroblasts)
					     (CODE -LRB-)
					     (PRN (NP (NN HF-NL)))))))))))
     (CODE -RRB-)
     (. .)))

( (S (NP-SBJ (DT This) (JJ phenotypical) (NN abnormality))
     (VP (MD could)
	 (VP (VB be)
	     (NP-PRD (NP (DT an) (JJ important) (NN factor))
		     (PP (IN in)
			 (NP (NP (DT the) (NN pathogenesis))
			     (PP (IN of)
				 (NP (NN IPF))))))))
     (. .)))

( (NP (NNS Materials) (CC and) (NNS methods)))

( (NP (JJ Primary) (NN lung) (NNS fibroblasts)))

( (S (NP-SBJ-1 (NP (NNS Fibroblasts))
	       (PP (IN from)
		   (NP (NP (DT the) (NNS lungs))
		       (PP (IN of)
			   (NP (NP (CD seven)
				   (NNS patients)
				   (CODE -LRB-)
				   (PRN (NP (CD 6) (NNS males))))
			       (CODE -RRB-)
			       (PP (IN with)
				   (NP (NN IPF)
				       (CODE -LRB-)
				       (PRN (NP (NN HF-IPF))))))))))
     (CODE -RRB-)
     (VP (VBD were)
	 (VP (VP (VBN harvested)
		 (NP (-NONE- *-1))
		 (: :)
		 (LST (LS a))
		 (CODE -RRB-)
		 (PP (IN from)
		     (NP (VBN excised) (NN lung)))
		 (PP-TMP (IN at)
			 (NP (NP (DT the) (NN time))
			     (PP (IN of)
				 (NP (NN lung) (NN transplantation))))))
	     (, ;)
	     (VP (LST (LS b))
		 (CODE -RRB-)
		 (PP-TMP (IN during)
			 (NP (DT an) (NN autopsy))
			 (VP (VBN performed)
			     (NP (-NONE- *))
			     (PP-TMP (IN within)
				     (NP (NP (CD 4) (NNS hours))
					 (PP (IN from)
					     (NP (NN death))))))))
	     (, ;)
	     (CC or)
	     (VP (LST (LS c))
		 (CODE -RRB-)
		 (PP-TMP (IN during)
			 (NP (ADJP (JJ open) (CC or) (JJ transbronchial))
			     (NN lung)
			     (NNS biopsies)))
		 (PP-TMP (IN at)
			 (NP (NP (DT the) (NN time))
			     (PP (IN of)
				 (NP (NN diagnosis))))))))
     (. .)))

( (S (S (PP-1 (IN Of)
	      (NP (DT the) (CD seven) (NNS patients)))
	(, ,)
	(NP-SBJ (NP (CD five) (NNS subjects))
		(PP (-NONE- *ICH*-1)))
	(VP (VP (VBD had)
		(NP (JJ advanced) (NN lung) (NN fibrosis)))
	    (CC and)
	    (VP (VBD were)
		(VP (VBG receiving)
		    (NP (NP (NN prednisone))
			(SYM ±�)
			(NP (JJ immunosuppressive) (NNS agents)))))))
     (, ;)
     (S (NP-SBJ (CD 2) (NNS patients))
	(VP (VBD were)
	    (PP-PRD (IN at)
		    (NP (NP (DT an) (JJR earlier) (NN stage))
			(PP (IN of)
			    (NP (PRP$ their) (NN disease))))))
	(CC and)
	(VP (VBD were)
	    (RB not)
	    (VP (VBG receiving)
		(NP (JJ immunosuppressive) (NNS drugs)))))
     (. .)))

( (S (NP-SBJ (NP (DT The) (NN mean) (NN age))
	     (PP (IN of)
		 (NP (DT the) (NNS patients))))
     (VP (VBD was)
	 (NP-PRD (NP (CD 59) (CODE -LRB-) (NN range))
		 (NP (CD 43) (SYM -) (CD 71))))
     (CODE -RRB-)
     (CODE <$$bracket>)
     (. .)))

( (S (S (NP-SBJ-1 (NP (NN HF-NL))
		  (PP (-NONE- *ICH*-2)))
	(VP (VBD were)
	    (VP (VBN cultured)
		(NP (-NONE- *-1))
		(PP-2 (IN from)
		      (NP (NP (CD five) (JJ human) (NNS lungs))
			  (SBAR (WHNP-3 (WDT that))
				(S (S (NP-SBJ (-NONE- *T*-3))
				      (VP (VBD arrived)
					  (PP-LOC (IN at)
						  (NP (PRP$ our) (NN transplant) (NN center)))
					  (PP (IN with)
					      (NP (NP (DT the) (NN intention))
						  (PP (IN of)
						      (S-NOM (NP-SBJ-4 (-NONE- *PRO*))
							     (VP (VBG being)
								 (VP (VBN used)
								     (NP (-NONE- *-4))
								     (PP-PRP (IN for)
									     (NP (NN transplantation)))))))))))
				   (, ,)
				   (CC but)
				   (S (NP-SBJ-5 (-NONE- *T*-3))
				      (PP-PRP (IN for)
					      (NP (JJ various) (NNS reasons)))
				      (VP (MD could)
					  (RB not)
					  (VP (VB be)
					      (VP (VBN transplanted)
						  (NP (-NONE- *-5)))))))))))))
     (, ;)
     (S (NP-SBJ (DT these))
	(VP (VBD were)
	    (ADJP-PRD (ADVP (RB macroscopically) (CC and) (RB microscopically))
		      (JJ normal))))
     (. .)))

( (S (NP-SBJ-1 (DT The) (NNS cells))
     (VP (VBD were)
	 (VP (VBN harvested)
	     (CC and)
	     (VBN cultured)
	     (NP (-NONE- *-1))
	     (PP-MNR (IN as)
		     (IN per)
		     (NP (NP (DT the) (NN protocol))
			 (VP (VBN described)
			     (NP (-NONE- *))
			     (PP (IN by)
				 (NP-LGS (NP (NNP Kumar) (FW et) (FW al.)))))))))
     (CODE {COM:footnote_indexical_omitted})
     (. .)))

( (S (ADVP (RB Briefly))
     (, ,)
     (NP-SBJ-1 (NML (NN lung) (NN tissue))
	       (NNS sections))
     (VP (VBD were)
	 (VP (ADVP (RB finely))
	     (VP (VBN cut)
		 (NP (-NONE- *-1))
		 (PP (IN with)
		     (NP (JJ sterile) (NNS scissors))))
	     (CC and)
	     (VP (VBN incubated)
		 (NP (-NONE- *-1))
		 (PP (IN with)
		     (NP (NP (NN serum) (JJ free) (NN DMEM))
			 (VP (VBG containing)
			     (NP (NN trypsin) (, ,) (NN DNAse) (CC and) (NN collagenase)))))
		 (PP-TMP (IN for)
			 (NP (CD 30) (NNS min))))))
     (. .)))

( (S (S (NP-SBJ-1 (DT The) (NN procedure))
	(VP (VBD was)
	    (VP (VBN repeated)
		(NP (-NONE- *-1))
		(ADVP-TMP (RB twice)))))
     (, ,)
     (CC and)
     (S (NP-SBJ-2 (DT the) (NNS supernatants))
	(VP (VBD were)
	    (VP (VP (VBN pooled)
		    (CC and)
		    (VBN cultured)
		    (NP (-NONE- *-2))
		    (PP-LOC (IN in)
			    (NP (CD one)
				(NML (CD 100) (NN mm))
				(NN plate))))
		(CC and)
		(VP (VBN incubated)
		    (NP (-NONE- *-2))
		    (PP (IN at)
			(NP (NML (CD 37) (NNS °))
			    (NNP C)))
		    (PP-LOC (IN in)
			    (NP (DT a)
				(NML (CD 5) (NN %))
				(ADJP (NN CO2) (VBN humidified))
				(NN atmosphere)))))))
     (. .)))

( (S (S (NP-SBJ-1 (NP (NN Culture)
		      (NN medium)
		      (CODE -LRB-)
		      (PRN (NP (NN DMEM))))
		  (PP (IN with)
		      (NP (NML (CD 5) (NN %))
			  (NP (JJ fetal)
			      (JJ bovine)
			      (NN serum)
			      (CODE <bracket>)
			      (PRN (NP (NN FBS))))
			  (CODE <$$bracket>)
			  (CC and)
			  (NP (NN penicillin) (SYM $$) (NN streptomycin)))))
	(CODE -RRB-)
	(VP (VBD was)
	    (VP (VBN replaced)
		(NP (-NONE- *-1))
		(NP-TMP (NP (CD three) (NNS times))
			(PP (IN per)
			    (NP (NN week)))))))
     (CC and)
     (S (NP-SBJ-2 (NNS fibroblasts))
	(VP (VBD were)
	    (VP (VBN passed)
		(NP (-NONE- *-2))
		(CODE -LRB-)
		(PRN (NP (QP (CD 1) (SYM :) (CD 2))
			 (NN split)))
		(CODE -RRB-)
		(PP-TMP (IN at)
			(NP (NP (DT the) (NN time))
			    (SBAR (WHNP-3 (-NONE- 0))
				  (S (NP-SBJ (PRP they))
				     (VP (VBD became)
					 (ADJP-PRD (JJ confluent))
					 (NP-TMP (-NONE- *T*-3))))))))))
     (. .)))

( (S (PP-TMP (IN On)
	     (NP (NN passage) (CD 4)))
     (NP-SBJ-1 (DT the) (NNS cells))
     (VP (VBD were)
	 (VP (VP (VBN resuspended)
		 (NP (-NONE- *-1))
		 (PP (IN in)
		     (NP (NP (CD 1) (NN ml))
			 (PP (IN of)
			     (NP (NN DMEM)))))
		 (PP (IN with)
		     (NP (NML (CD 20) (NN %))
			 (NN FBS)
			 (CC and)
			 (NN DMSO))))
	     (CC and)
	     (VP (VBN frozen)
		 (NP (-NONE- *-1))
		 (PP (IN at)
		     (NP (NML (CD -70) (NNS °))
			 (NNP C))))))
     (. .)))

( (S (PP (IN For)
	 (NP (NP (DT each) (NN experiment))
	     (VP (VBN described)
		 (NP (-NONE- *))
		 (ADVP-LOC (RB below)))))
     (NP-SBJ-1 (DT the) (NNS cells))
     (VP (VBD were)
	 (VP (VBN thawed)
	     (, ,)
	     (VBN cultured)
	     (CC and)
	     (VBN passed)
	     (NP (-NONE- *-1))
	     (ADVP-TMP (ADVP (RB at) (RB least))
		       (RB once))))
     (. .)))

( (S (NP-SBJ-1 (PDT All) (DT the) (NNS experiments))
     (VP (VBD were)
	 (VP (VBN conducted)
	     (NP (-NONE- *-1))
	     (PP (IN with)
		 (NP (NP (NNS cells))
		     (PP (IN at)
			 (NP (NNS passages)
			     (QP (CD 6) (IN to) (CD 8))))))))
     (. .)))

( (NP (NP (JJ Inducible)
	  (NN cyclooxygenase)
	  (CODE -LRB-)
	  (PRN (NP (NN COX)))
	  (CODE -RRB-)
	  (CD -2)
	  (NN expression))
      (CC and)
      (NP (NN eicosanoid) (NN production))))

( (S (NP-SBJ-1 (NN COX-2) (NN activity))
     (VP (VBD was)
	 (VP (VBN determined)
	     (NP (-NONE- *-1))
	     (PP-MNR (IN by)
		     (S-NOM (NP-SBJ (-NONE- *PRO*))
			    (VP (VBG measuring)
				(NP (NP (NN PGE) (CD 2))
				    (, ,)
				    (NP (NP (NN 6-keto-PGF) (NN 1?))
					(CODE -LRB-)
					(NP (JJ stable)
					    (NML (NN PGI) (CD 2))
					    (NN metabolite)))
				    (CODE -RRB-)
				    (, ,)
				    (NP (NP (NN TXB) (CD 2))
					(CODE -LRB-)
					(NP (JJ stable)
					    (NML (NN TXA) (CD 2))
					    (NN metabolite)))
				    (CODE -RRB-)
				    (, ,)
				    (CC and)
				    (NP (NML (NN PGF) (NN 2?))
					(NN production)))
				(PP (IN in)
				    (NP (VBN stimulated) (NNS fibroblasts))))))))
     (. .)))

( (S (NP-SBJ-1 (NP (NN HF-IPF))
	       (CODE -LRB-)
	       (PRN (S (NP-SBJ (NN n))
		       (VP (VBZ =)
			   (NP-PRD (CD 7) (CODE -RRB-)))))
	       (CC and)
	       (NP (NN HF-NL))
	       (CODE -LRB-)
	       (PRN (S (NP-SBJ (NN n))
		       (VP (VBZ =)
			   (NP-PRD (CD 5))))))
     (CODE -RRB-)
     (VP (VBD were)
	 (VP (VP (VBN brought)
		 (NP (-NONE- *-1))
		 (PP-EXT (IN to)
			 (NP (QP (QP (SYM >) (CD 90))
				 (NN %))
			     (NN confluency)))
		 (PP-LOC (IN in)
			 (NP (QP (CD 100) (NN mm))
			     (NNS plates))))
	     (CONJP (CC and) (RB then))
	     (VP (VBN placed)
		 (NP (-NONE- *-1))
		 (PP-LOC (IN on)
			 (NP (ADJP (NN serum) (JJ free))
			     (NN DMEM)))
		 (PP-TMP (IN for)
			 (NP (CD 24) (NNS hours))))
	     (S-PRP (NP-SBJ (-NONE- *PRO*))
		    (VP (TO to)
			(VP (VB render)
			    (S (NP-SBJ (PRP them))
			       (ADJP-PRD (JJ quiescent))))))))
     (. .)))

( (S (NP-SBJ-1 (NNS Fibroblasts))
     (VP (VBD were)
	 (ADVP-TMP (RB then))
	 (VP (VP (VBN incubated)
		 (NP (-NONE- *-1))
		 (PP-LOC=2 (IN in)
			   (NP (NN DMEM)))
		 (PP=3 (IN with)
		       (NP (NML (CD 5) (NN %))
			   (NN FBS)))
		 (S-ADV (NP-SBJ (-NONE- *PRO*-1))
			(ADJP-PRD (JJ alone))))
	     (CC or)
	     (VP (PP-LOC=2 (IN in)
			   (NP (DT the) (JJ same) (NN medium)))
		 (PP=3 (IN with)
		       (NP (NN IL-1?)
			   (CODE -LRB-)
			   (PRN (NP (NP (CD 2.5) (NNS ng))
				    (PP (SYM $$)
					(NP (NN ml))))))))
	     (CODE -RRB-)
	     (PP-TMP (IN for)
		     (NP (CD 24) (NNS hours)))))
     (. .)))

( (S (S (PP-TMP (IN At)
		(NP (NP (DT the) (NN end))
		    (PP (IN of)
			(NP (DT the) (NN incubation) (NN period)))))
	(NP-SBJ-1 (DT the) (NN supernatant))
	(VP (VBD was)
	    (VP (VBN aspirated)
		(NP (-NONE- *-1)))))
     (CC and)
     (S (NP-SBJ-2 (NP (JJ fresh) (NNS media))
		  (VP (VBG containing)
		      (NP (NP (CD 30) (NNS ?M))
			  (PP (IN of)
			      (NP (JJ arachidonic) (NN acid))))))
	(VP (VBD was)
	    (VP (VBN added)
		(NP (-NONE- *-2))
		(PP-CLR (IN to)
			(NP (DT the) (NNS plates))))))
     (. .)))

( (S (PP-TMP (IN After)
	     (NP (NP (CD 30) (NNS min))
		 (PP (IN of)
		     (NP (NN incubation)))))
     (NP-SBJ-1 (DT the) (NN supernatant))
     (VP (VBD was)
	 (VP (VBN collected)
	     (CC and)
	     (VBN saved)
	     (NP (-NONE- *-1))
	     (PP (IN at)
		 (NP (NML (CD -70) (NNS °))
		     (NNP C)))
	     (PP-PRP (IN for)
		     (NP (JJR later) (NN eicosanoid) (NN analysis)))))
     (. .)))

( (S (NP-SBJ-1 (DT The) (NNS cells))
     (VP (VBD were)
	 (ADVP-TMP (RB then))
	 (VP (VBN resuspended)
	     (CC and)
	     (VBN divided)
	     (NP (-NONE- *-1))
	     (PP-CLR (IN into)
		     (NP (NP (CD two) (NNS aliquots))
			 (, ,)
			 (SBAR (WHNP-2 (WP which))
			       (S (NP-SBJ-3 (-NONE- *T*-2))
				  (VP (VBD were)
				      (VP (VBN used)
					  (NP (-NONE- *-3))
					  (PP-PRP (IN for)
						  (NP (NML (NN RNA) (CC and) (NN protein))
						      (NNS extractions)
						      (, ,)
						      (ADVP (RB respectively))))))))))))
     (. .)))

( (S (NP-SBJ-1 (DT The) (RB above) (NNS experiments))
     (VP (VBD were)
	 (VP (VBN repeated)
	     (NP (-NONE- *-1))
	     (PP (IN in)
		 (NP (NN HF-IPF)
		     (CODE -LRB-)
		     (PRN (S (NP-SBJ (NN n))
			     (VP (VBZ =)
				 (NP-PRD (CD 2)))))
		     (CODE -RRB-)
		     (CC and)
		     (NN HF-NL)
		     (CODE -LRB-)
		     (PRN (S (NP-SBJ (NN n))
			     (VP (VBZ =)
				 (NP-PRD (CD 2)))))))
	     (CODE -RRB-)
	     (S-ADV (NP-SBJ (-NONE- *PRO*))
		    (VP (VBG using)
			(NP (ADJP (NN serum) (JJ free))
			    (NNS media)
			    (NNS conditions))))))
     (. .)))

( (S (NP-SBJ-1 (NNS Prostanoids))
     (VP (VBD were)
	 (VP (VBN measured)
	     (NP (-NONE- *-1))
	     (PP (IN by)
		 (NP-LGS (NP (VBN modified)
			     (NML (NML (JJ stable) (NN isotope))
				  (NN dilution))
			     (NNS assays))
			 (SBAR (WHNP-2 (WDT that))
			       (S (NP-SBJ (-NONE- *T*-2))
				  (VP (VBZ used)
				      (NP (NML (NML (NN gas) (NN chromatography))
					       (HYPH -)
					       (NML (NML (JJ negative) (NN ion) (HYPH -) (JJ chemical))
						    (NN ionization)))
					  (JJ mass)
					  (NN spectrometry))
				      (SBAR-MNR (IN as)
						(S (NP-SBJ-3 (-NONE- *PRO*))
						   (ADVP-TMP (RB previously))
						   (VP (VBN described)
						       (NP (-NONE- *-3))))))))))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (ADVP (RB Briefly))
     (, ,)
     (NP-SBJ-1 (NP (ADJP (NN deuterium) (HYPH -) (VBN labeled))
		   (JJ internal)
		   (NNS standards))
	       (PP (IN of)
		   (NP (NP (NN PGE) (CD 2))
		       (, ,)
		       (NP (NN PGF) (NN 2?))
		       (, ,)
		       (NP (NN TXB) (CD 2))
		       (, ,)
		       (CC and)
		       (NP (NN 6-keto-PGF) (NN 1?)))))
     (VP (VBD were)
	 (VP (VBN added)
	     (NP (-NONE- *-1))
	     (PP-CLR (IN to)
		     (NP (DT the) (NNS supernatants)))
	     (PP (IN with)
		 (NP (NN isopropyl) (NN alcohol)))))
     (. .)))

( (S (NP-SBJ-1 (NN Isopropyl) (NN alcohol))
     (VP (VBD was)
	 (VP (VBN removed)
	     (NP (-NONE- *-1))
	     (PP (IN by)
		 (NP-LGS (NP (NN evaporation))
			 (PP (IN under)
			     (NP (NN nitrogen)))))))
     (. .)))

( (S (PP-TMP (IN After)
	     (NP (NP (NN acidification))
		 (PP (IN to)
		     (NP (NN pH)
			 (QP (CD 3.5))))))
     (, ,)
     (NP-SBJ-1 (DT the) (NNS samples))
     (VP (VBD were)
	 (VP (VP (VBN extracted)
		 (NP (-NONE- *-1))
		 (PP-LOC (IN on)
			 (NP (VBN preconditioned)
			     (NML (NN C-18) (NN PrepSep))
			     (NNS columns)
			     (CODE -LRB-)
			     (REF (FRAG (NP (NNP Fisher) (NNP Scientific))
					(, ,)
					(NP (NNP Fair) (NNP Lawn))
					(, ,)
					(NP (NNP NJ)))))))
	     (CODE -RRB-)
	     (, ,)
	     (CC and)
	     (VP (VBN eluted)
		 (NP (-NONE- *-1))
		 (PP (IN with)
		     (NP (NN ethyl) (NN acetate))))))
     (. .)))

( (S (NP-SBJ-1 (DT The) (NN extract))
     (VP (VBD was)
	 (ADVP-TMP (RB then))
	 (VP (VBN converted)
	     (NP (-NONE- *-1))
	     (PP-CLR (IN to)
		     (NP (DT a) (NN pentafluorobenzyl) (NN ester)))
	     (PP (IN by)
		 (NP-LGS (NP (NN treatment))
			 (PP (IN with)
			     (NP (NP (DT a) (NN mixture))
				 (PP (IN of)
				     (NP (NML (CD 12.5) (NN %))
					 (NN pentafluorobenzyl)
					 (NN bromide)))))))
	     (PP (IN in)
		 (NP (NN acetonitrile) (CC and) (NN disopropylethylamine)))
	     (PP (IN at)
		 (NP (NN room) (NN temperature)))
	     (PP-TMP (IN for)
		     (NP (CD 30) (NNS min)))))
     (. .)))

( (S (PP-TMP (IN After)
	     (NP (NP (NN evaporation))
		 (PP (IN of)
		     (NP (NNS reagents)))))
     (, ,)
     (NP-SBJ-1 (DT the) (NN residue))
     (VP (VBD was)
	 (VP (VBN subjected)
	     (NP (-NONE- *-1))
	     (PP (IN to)
		 (NP (NN TLC) (NNS plates)))
	     (, ,)
	     (S-ADV (NP-SBJ (-NONE- *PRO*))
		    (VP (VP (VBG using)
			    (NP=2 (DT the)
				  (NN solvent)
				  (NN system)
				  (NML (NN chloroform) (SYM $$) (NN ethanol))
				  (CODE -LRB-)
				  (PRN (NP (QP (CD 93) (SYM :) (CD 7))
					   (, ,)
					   (NN vol)
					   (SYM $$)
					   (NN vol))))
			    (CODE -RRB-)
			    (PP-PRP=3 (IN for)
				      (NP (NP (NN PGF) (NN 2?))
					  (CC and)
					  (NP (NN TXB) (CD 2)))))
			(, ,)
			(CC and)
			(VP (NP=2 (NML (NML (NN ethyl) (NN acetate))
				       (SYM $$)
				       (NML (NN methanol)))
				  (CODE -LRB-)
				  (PRN (NP (QP (CD 93) (SYM :) (CD 2))
					   (, ,)
					   (NN vol)
					   (SYM $$)
					   (NN vol))))
			    (CODE -RRB-)
			    (PP-PRP=3 (IN for)
				      (NP (NP (NN 6-keto-PGF) (NN 1?))
					  (CC and)
					  (NP (NN PGE) (CD 2)))))))))
     (. .)))

( (S (ADVP-TMP (RB Then))
     (NP-SBJ-1 (NN PGF) (NN 2?))
     (VP (VBD was)
	 (VP (VBN converted)
	     (NP (-NONE- *-1))
	     (PP-CLR (IN to)
		     (NP (NML (NN trimethylsilyl) (NN ether))
			 (NN derivative)))
	     (PP-MNR (IN by)
		     (NP (NP (NN treatment))
			 (PP (IN with)
			     (NP (NN N,O-bis) (CODE -LRB-) (NN trimethylsilyl) (CODE -RRB-) (NN trifluoroacetamide) (CC and) (NN dimethylformamide)))))))
     (. .)))

( (S (NP-SBJ-1 (NP (DT The) (NN methoxime) (NN derivative))
	       (PP (IN of)
		   (NP (NP (NN TXB) (CD 2))
		       (, ,)
		       (NP (NN PGE) (CD 2))
		       (CC and)
		       (NP (NN 6-keto-PGF) (NN 1?)))))
     (VP (VBD was)
	 (VP (VBN made)
	     (NP (-NONE- *-1))
	     (PP (IN by)
		 (NP-LGS (NP (NN treatment))
			 (PP (IN with)
			     (NP (NML (CD 2) (NN %))
				 (NN methoxamine)
				 (NN hydrochloride)))
			 (PP (IN in)
			     (NP (NN pyridine)))))
	     (PP (IN at)
		 (NP (NML (CD 70) (NNS °))
		     (NNP C)))
	     (PP-TMP (IN for)
		     (NP (CD 60) (NNS min)))
	     (, ,)
	     (S-ADV (NP-SBJ-2 (-NONE- *PRO*))
		    (VP (VBN followed)
			(NP (-NONE- *-2))
			(PP (IN by)
			    (NP-LGS (NP (NP (NN evaporation))
					(PP (IN of)
					    (NP (DT the) (NN pyridine))))
				    (, ,)
				    (NP (NP (NN addition))
					(PP (IN of)
					    (NP (NN water))))
				    (, ,)
				    (CC and)
				    (NP (NP (NN extraction))
					(PP (IN with)
					    (NP (NN ethyl) (NN acetate))))))))))
     (. .)))

( (S (NP-SBJ-1 (NN Derivatization))
     (VP (VBD was)
	 (VP (VBN completed)
	     (NP (-NONE- *-1))
	     (PP-TMP (IN by)
		     (NP (NP (NN formation))
			 (PP (IN of)
			     (NP (DT the) (NN trimethylsilyl) (NNS derivatives)))))
	     (PP (IN by)
		 (NP-LGS (NP (NN treatment))
			 (PP (IN with)
			     (NP (NN N,O-bis)
				 (CODE -LRB-)
				 (PRN (NP (NN trimethylsilyl)))
				 (CODE -RRB-)
				 (NN trifluoroacetamide)
				 (CC and)
				 (NN pyridine)))))))
     (. .)))

( (S (NP-SBJ-1 (NNS Eicosanoids))
     (VP (VBD were)
	 (VP (VBN quantified)
	     (NP (-NONE- *-1))
	     (PP-MNR (IN by)
		     (S-NOM (NP-SBJ (-NONE- *PRO*))
			    (VP (VBG measuring)
				(NP (NP (DT the) (NN ratio))
				    (PP (IN of)
					(NP (NP (DT the) (NN intensity))
					    (PP (IN of)
						(FRAG (FRAG (NP (NNS ions) (NNS m) (SYM $$) (NN z) (CD 569) (SYM $$) (CD 573))
							    (PP (IN for)
								(NP (NN PGF) (NN 2?))))
						      (, ,)
						      (FRAG (NP (NNS m) (SYM $$) (NN z) (CD 614) (SYM $$) (CD 618))
							    (PP (IN for)
								(NP (NML (NN TXB) (CD 2) (CC and) (NN 6-keto-PGF))
								    (NN 1?))))
						      (, ,)
						      (CC and)
						      (FRAG (NP (NNS m) (SYM $$) (NN z) (CD 524) (SYM $$) (CD 528))
							    (PP (IN for)
								(NP (NN PGE) (CD 2))))))))))))))
     (. .)))

( (S (NP-SBJ-1 (NP (DT An) (JJ analytical) (NN blank))
	       (PP (IN for)
		   (NP (NP (DT each))
		       (PP (IN of)
			   (NP (DT these) (NNS products))))))
     (VP (VBD was)
	 (VP (VBN determined)
	     (NP (-NONE- *-1))
	     (PP-MNR (IN by)
		     (S-NOM (NP-SBJ (-NONE- *PRO*))
			    (VP (VBG measuring)
				(NP (NP (DT the) (NN amount))
				    (PP (IN of)
					(NP (JJ nondeuterated) (NN material)))
				    (, ,)
				    (VP (VBN detected)
					(NP (-NONE- *))
					(SBAR-TMP (IN after)
						  (S (NP-SBJ (-NONE- *PRO*))
						     (VP (VBG extracting)
							 (CC and)
							 (VBG analyzing)
							 (NP (NP (QP (CD 3) (NNS ml) (IN of))
								 (NN saline))
							     (SBAR (WHPP-2 (IN to)
									   (WHNP (WP which)))
								   (S (NP-SBJ-3 (DT the)
										(ADJP (NN deuterium) (HYPH -) (VBN labeled))
										(JJ internal)
										(NNS standards))
								      (VP (VBD had)
									  (VP (VBN been)
									      (VP (VBN added)
										  (NP (-NONE- *-3))
										  (PP-CLR (-NONE- *T*-2))))))))))))))))))
     (. .)))

( (NP (JJ Western) (NN analysis)))

( (S (SBAR-TMP (IN After)
	       (S (NP-SBJ (-NONE- *PRO*))
		  (VP (VBG washing)
		      (PP (IN with)
			  (NP (NN PBS)))
		      (PP (IN at)
			  (NP (NN pH) (CD 7.4))))))
     (, ,)
     (NP-SBJ-1 (NNS pellets))
     (VP (VBD were)
	 (VP (VP (VBN lyzed)
		 (NP (-NONE- *-1))
		 (PP-LOC (IN in)
			 (NP (NP (NN solubilization) (NN buffer))
			     (VP (VBG containing)
				 (NP (NP (NP (NP (QP (CD 50) (NNS mM))
						 (NN TRIS))
					     (PP (IN at)
						 (NP (NN pH) (CD 8))))
					 (, ,)
					 (NP (QP (CD 1) (NN %))
					     (NN Tween)
					     (CD 20))
					 (, ,)
					 (NP (QP (CD 10) (NNS mM))
					     (NN phenylmethylsulphonyl)
					     (NN fluoride))
					 (, ,)
					 (NP (JJ diethyldithiocarbamic) (NN acid))
					 (, ,)
					 (NP (NN leupeptin))
					 (CC and)
					 (NP (NN pepstatin) (NN A)))
				     (CODE -LRB-)
				     (PP (RB all)
					 (IN from)
					 (NP (NNP Sigma) (NNP Chemical))))))))
	     (CODE -RRB-)
	     (, ,)
	     (VP (VBN sonicated)
		 (NP (-NONE- *-1)))
	     (, ,)
	     (VP (VBN boiled)
		 (NP (-NONE- *-1))
		 (PP (IN with)
		     (NP (NML (NN gel) (NN loading))
			 (NN buffer)
			 (CODE -LRB-)
			 (PRN (NP (NP (QP (CD 62.5) (NNS mM))
				      (NN TRIS-HCl))
				  (, ,)
				  (PP (IN at)
				      (NP (NN pH) (CD 6.8)))
				  (, ,)
				  (NP (QP (CD 10) (NN %))
				      (NN glycerol))
				  (, ,)
				  (NP (QP (CD 2) (NN %))
				      (NN SDS))
				  (, ,)
				  (NP (QP (CD 5) (NN %))
				      (NN ?-mercaptoethanol))
				  (, ,)
				  (CC and)
				  (NP (NN bromophenol) (NN blue)))))))
	     (CODE -RRB-)
	     (, ,)
	     (CC and)
	     (VP (VBN centrifuged)
		 (NP (-NONE- *-1))
		 (PP-MNR (IN at)
			 (NP (QP (CD 15,000) (NN x))
			     (NN g)))
		 (PP-TMP (IN for)
			 (NP (CD 10) (NNS min))))))
     (. .)))

( (S (NP-SBJ-1 (NP (JJ Equal) (NNS amounts))
	       (PP (IN of)
		   (NP (NN protein))
		   (CODE -LRB-))
	       (PRN (NP (CD 70)
			(QP (IN to) (CD 100))
			(NNS RSQUOg))))
     (CODE -RRB-)
     (VP (VBD were)
	 (VP (VBN separated)
	     (NP (-NONE- *-1))
	     (PP (IN by)
		 (NP-LGS (NN electrophoresis)))))
     (. .)))

( (S (NP-SBJ-1 (NN SDS-PAGE))
     (VP (VBD was)
	 (VP (VBN performed)
	     (NP (-NONE- *-1))
	     (S-ADV (NP-SBJ (-NONE- *PRO*))
		    (VP (VBG using)
			(NP (DT a)
			    (NML (CD 7.5) (NN %))
			    (VBG separating)
			    (NN gel))
			(PP (IN with)
			    (NP (DT a)
				(NML (CD 4) (NN %))
				(VBG stacking)
				(NN gel)))))))
     (. .)))

( (S (NP-SBJ-1 (DT The) (VBN resolved) (NNS proteins))
     (VP (VBD were)
	 (VP (VBN transferred)
	     (NP (-NONE- *-1))
	     (ADVP-MNR (RB electrophoretically))
	     (PP (IN to)
		 (NP (NN nitrocellulose)
		     (NNS membranes)
		     (CODE -LRB-)
		     (PRN (FRAG (NP (NNP Hybond-ECL))
				(, ,)
				(NP (NNP Amersham) (NNP Corp.))))))))
     (CODE -RRB-)
     (. .)))

( (S (PP-TMP (IN After)
	     (NP (NN transfer)))
     (, ,)
     (NP-SBJ-1 (DT the) (NNS filters))
     (VP (VBD were)
	 (VP (VP (VBN incubated)
		 (NP (-NONE- *-1))
		 (ADVP-TMP (RB overnight))
		 (PP (IN at)
		     (NP (NML (CD 4) (NNS °))
			 (NNP C)
			 (PP (IN in)
			     (NP (NP (DT a) (VBG blocking) (NN solution))
				 (CODE -LRB-)
				 (PRN (NP (NP (NML (CD 20) (NNS mM))
					      (NN TRIS)
					      (NN base))
					  (, ,)
					  (NP (NP (NML (CD 137) (NNS mM))
						  (NN sodium)
						  (NN chloride))
					      (PP (IN at)
						  (NP (NN pH)
						      (QP (CD 7.6)))))
					  (, ,)
					  (NP (NML (CD 5) (NN %))
					      (VBN powdered)
					      (NN milk))
					  (, ,)
					  (NP (NML (CD 3) (NN %))
					      (NN BSA)))))))))
	     (CODE -RRB-)
	     (, ,)
	     (CC and)
	     (VP (VBN incubated)
		 (NP (-NONE- *-1))
		 (PP (IN with)
		     (NP (JJ primary) (JJ polyclonal) (NN rabbit) (NNS antibodies)))
		 (PP (IN against)
		     (NP (NN COX-2)))
		 (PP (IN at)
		     (NP (DT a)
			 (NN dilution)
			 (QP (CD 1) (SYM :) (CD 1000))
			 (CODE -LRB-)
			 (PRN (FRAG (NP (NNP Cayman) (NNP Chemical))
				    (, ,)
				    (NP (NNP Ann) (NNP Arbor))
				    (, ,)
				    (NP (NNP MI))))))
		 (CODE -RRB-)
		 (, ,)
		 (PP-TMP (IN for)
			 (NP (CD 1) (NN hour)))
		 (PP (IN at)
		     (NP (NN room) (NN temperature))))))
     (. .)))

( (S (NP-SBJ-1 (DT The) (NNS filters))
     (VP (VBD were)
	 (VP (VP (VBN washed)
		 (NP (-NONE- *-1))
		 (CODE -LRB-)
		 (REF (NP (NN TBS)
			  (NML (CD -0.1) (NN %))
			  (NN Tween)
			  (CD 20))
		      (PP (IN at)
			  (NP (NN pH) (CD 7.6)))))
	     (CODE -RRB-)
	     (CC and)
	     (VP (VBN incubated)
		 (NP (-NONE- *-1))
		 (PP (IN with)
		     (NP (ADJP (NML (NN horseradish) (NN peroxidase))
			       (VBN linked))
			 (JJ secondary)
			 (NNS antibodies)))
		 (PP (IN at)
		     (NP (DT a)
			 (NN dilution)
			 (QP (CD 1) (SYM :) (CD 4000))
			 (CODE -LRB-)
			 (PRN (NP (NNP Amersham))))))))
     (CODE -RRB-)
     (. .)))

( (S (SBAR-TMP (IN After)
	       (S (NP-SBJ (-NONE- *PRO*))
		  (VP (VBG washing))))
     (, ,)
     (NP-SBJ-1 (DT the) (NNS membranes))
     (VP (VBD were)
	 (VP (VBN incubated)
	     (NP (-NONE- *-1))
	     (PP (IN with)
		 (NP (ADJP (NN luminol) (VBN based))
		     (NN chemiluminescence)
		     (NN reagent)
		     (CODE -LRB-)
		     (PRN (NP (NML (NNP DuPont) (NNP NEN))
			      (NNP Research)
			      (NNPS Products))
			  (, ,)
			  (NP (NNP Boston))
			  (, ,)
			  (NP (NNP MA)))))))
     (CODE -RRB-)
     (. .)))

( (NP (JJ Northern) (NN analysis)))

( (S (S (NP-SBJ-1=1 (NN Cell) (NNS pellets))
	(VP (VBD were)
	    (VP=2 (VBN lyzed)
		  (NP (-NONE- *-1)))))
     (CC and)
     (S (NP-SBJ-2=1 (NN RNA))
	(VP=2 (VBN extracted)
	      (NP (-NONE- *-2))
	      (S-MNR (NP-SBJ (-NONE- *PRO*))
		     (VP (VBG using)
			 (NP (NP (DT the) (NNP RNeasy) (NN method))
			     (SYM ®)
			     (CODE -LRB-)
			     (NP (NNP Qiagen))
			     (CODE -RRB-))))
	      (, ,)
	      (S-ADV (NP-SBJ (-NONE- *PRO*))
		     (VP (VBG following)
			 (NP (NP (DT the) (NN manufacturer) (POS 's))
			     (NNS instructions))))))
     (. .)))

( (S (NP-SBJ-1 (NN RNA))
     (VP (VBD was)
	 (VP (VP (VBN quantified)
		 (NP (-NONE- *-1))
		 (PP-MNR (IN by)
			 (S-NOM (NP-SBJ (-NONE- *PRO*))
				(VP (VBG determining)
				    (NP (NN light) (NN absorbance))
				    (PP (IN at)
					(NP (CD 260) (NNS nm)))))))
	     (CONJP (CC and) (RB then))
	     (VP (VBN fractioned)
		 (NP (-NONE- *-1))
		 (PP (IN by)
		     (NP-LGS (NN electrophoresis)
			     (CODE -LRB-)
			     (QP (CD 10)
				 (NNS RSQUOg)
				 (PP (IN per)
				     (NP (NN lane))))))
		 (CODE -RRB-)
		 (PP (IN on)
		     (NP (DT a)
			 (NML (CD 1) (NN %))
			 (NN agarose)
			 (NML (NN MOPS) (SYM $$) (NN formaldehyde))
			 (NN gel))))))
     (. .)))

( (S (NP-SBJ-1 (DT The) (NN RNA))
     (VP (VBD was)
	 (VP (VBN denatured)
	     (NP (-NONE- *-1))
	     (ADVP-TMP (ADVP (RB prior))
		       (PP (IN to)
			   (NP (NN loading))))
	     (PP-MNR (IN by)
		     (S-NOM (NP-SBJ (-NONE- *PRO*))
			    (VP (VBG incubating)
				(NP (DT the) (NN RNA))
				(PP (IN at)
				    (NP (NML (NN 65) (NNS °))
					(NNP C)))
				(PP-TMP (IN for)
					(NP (CD 10) (NNS min)))
				(PP-LOC (IN in)
					(NP (NP (DT a) (VBG loading) (NN buffer))
					    (VP (VBG comprising)
						(NP (NP (NML (CD 1) (SYM X))
							(NN MOPS))
						    (, ,)
						    (NP (NML (CD 50) (NN %))
							(NN formamide))
						    (, ,)
						    (NP (NML (CD 6.5) (NN %))
							(NN formaldehyde))
						    (, ,)
						    (NP (NML (CD 5) (NN %))
							(NN glycerol))
						    (, ,)
						    (NP (NML (CD 0.1) (NNS mM))
							(NNP EDTA))
						    (, ,)
						    (NP (NML (CD 0.025) (NN %))
							(NN bromophenol)
							(NN blue))
						    (, ,)
						    (NP (NML (CD 0.025) (NN %))
							(NN xylene)
							(NN cyanol)))))))))))
     (. .)))

( (S (NP-SBJ-1 (DT The) (NN RNA))
     (VP (VBD was)
	 (VP (VP (VBN transferred)
		 (NP (-NONE- *-1))
		 (PP (IN by)
		     (NP-LGS (ADJP (NN gravity) (HYPH -) (VBN assisted) (JJ capillary) (NN method))))
		 (PP (IN with)
		     (NP (CD 6) (SYM X) (NN SSC)))
		 (PP (IN to)
		     (NP (NML (NN nylon) (NN hybridization))
			 (NN membrane))))
	     (, ,)
	     (CONJP (CC and) (RB then))
	     (VP (VBN fixed)
		 (NP (-NONE- *-1))
		 (PP (IN to)
		     (NP (DT the) (NN membrane)))
		 (PP (IN by)
		     (NP-LGS (NN UV)
			     (NN crosslinking)
			     (CODE -LRB-)
			     (PRN (FRAG (NP (NNP Stratalinker))
					(NP (CD 1200) (NNS RSQUOj) (SYM $$) (NN cm) (CD 2)))))))))
     (CODE -RRB-)
     (. .)))

( (S (NP-SBJ-1 (NN Prehybridization) (CC and) (NN hybridization))
     (VP (VBD were)
	 (VP (VBN performed)
	     (NP (-NONE- *-1))
	     (UCP (PP (IN at)
		      (NP (NML (CD 42) (NNS °))
			  (NNP C)))
		  (CC and)
		  (S-ADV (NP-SBJ (-NONE- *PRO*))
			 (VP (VBG using)
			     (NP (NNP Quick)
				 (NNP Hyb)
				 (SYM ®)
				 (CODE -LRB-)
				 (PRN (NP (NNP Stratagene))))
			     (CODE -RRB-)
			     (PP-PRP (IN as)
				     (NP (NN hybridization) (NN solution))))))))
     (. .)))

( (S (NP-SBJ (DT The) (NN COX-2) (NN probe))
     (VP (VBD was)
	 (VP (GW random)
	     (VBN primed)
	     (S-ADV (NP-SBJ (-NONE- *PRO*))
		    (VP (VBG following)
			(NP (NP (DT the) (NNS directions))
			    (PP (IN of)
				(NP (DT the)
				    (NN manufacturer)
				    (CODE -LRB-)
				    (PRN (NP (NNP Megaprime) (SYM ®) (, ,) (NNP Amersham) (SYM $$) (NNP Pharmacia))))))))))
     (CODE -RRB-)
     (. .)))

( (S (NP-SBJ-1 (DT The) (NN membrane))
     (VP (VBD was)
	 (ADVP-TMP (RB then))
	 (VP (VBN washed)
	     (NP (-NONE- *-1))
	     (PP (IN at)
		 (NP (NP (DT a) (JJ final) (NN stringency))
		     (PP (IN of)
			 (NP (NP (CD 0.2) (SYM X) (NN SSC))
			     (, ,)
			     (NP (NML (CD 0.1) (NN %))
				 (NN SDS))))))
	     (, ,)
	     (PP (IN at)
		 (NP (NML (CD 60) (NNS °))
		     (NNP C)))
	     (PP-TMP (IN for)
		     (NP (CD 30) (NNS min)))))
     (. .)))

( (S (NP-SBJ (DT The) (NN membrane))
     (VP (VBD was)
	 (VP (VP (VBN wrapped)
		 (PP-LOC (IN in)
			 (NP (JJ plastic) (NN wrap))))
	     (CC and)
	     (VP (VBN exposed)
		 (PP (IN to)
		     (NP (NML (NML (NNP Kodak) (NN XR) (NN film))
			      (PP (IN at)
				  (NP (CD -70) (NNS °))))
			 (NNP C)))
		 (PP-LOC (IN with)
			 (NP (NN intensifier) (NN screen)))
		 (ADVP-TMP (RB overnight)))))
     (. .)))

( (NP (JJ Statistical) (NNS methods)))

( (S (NP-SBJ-1 (DT All) (NNS results))
     (VP (VBP are)
	 (VP (VBN presented)
	     (NP (-NONE- *-1))
	     (PP-CLR (IN as)
		     (NP (NNS medians)))
	     (PP (IN with)
		 (NP (PRP$ their) (NN range)))))
     (. .)))

( (S (NP-SBJ-1 (NP (NNS Comparisons))
	       (PP (IN between)
		   (NP (NN HF-IPF) (CC and) (NN HF-NL))))
     (VP (VBD were)
	 (VP (VBN done)
	     (NP (-NONE- *-1))
	     (S-ADV (NP-SBJ (-NONE- *PRO*-1))
		    (VP (VBG using)
			(NP (DT the)
			    (NML (NNP Mann) (HYPH -) (NNP Whitney))
			    (NN test))))))
     (. .)))

( (S (NP-SBJ-1 (NP (NP (DT A) (NN P) (NN value))
		   (PP (IN of)
		       (NP (SYM <) (CD 0.05)))))
     (VP (VBD was)
	 (VP (VBN considered)
	     (S (NP-SBJ (-NONE- *-1))
		(ADJP-PRD (JJ significant)))))
     (. .)))

( (NP (NNS Results)))

( (NP (NP (ADJP (JJ Baseline) (CC and) (VBN stimulated))
	  (NN COX-2)
	  (NN activity))
      (PP (IN in)
	  (NP (NN HF-IPF) (CC and) (NN HF-NL)))))

( (S (NP-SBJ (JJ Unstimulated) (NN eicosanoid) (NN production))
     (VP (VBD was)
	 (ADJP-PRD (JJ similar))
	 (PP (IN in)
	     (NP (CC both) (NN HF-IPF) (CC and) (NN HF-NL))))
     (CODE -LRB-)
     (REF (NP (NN Fig.) (CD 1))
	  (, ,)
	  (NP (NP (NN a))
	      (PP (SYM -)
		  (NP (NN d)))))
     (CODE -RRB-)
     (. .)))

( (S (SBAR-TMP (WHADVP-1 (WRB When))
	       (S (NP-SBJ-2 (NNS fibroblasts))
		  (VP (VBD were)
		      (VP (VBN stimulated)
			  (NP (-NONE- *-2))
			  (PP (IN with)
			      (NP (NN IL-1?)))
			  (ADVP-TMP (-NONE- *T*-1))))))
     (NP-SBJ (EX there))
     (VP (VBD was)
	 (NP-PRD (NP (DT a)
		     (ADJP (JJ significant) (CC and) (JJ similar))
		     (NN upregulation))
		 (PP (IN of)
		     (NP (NML (NN PGE) (CD 2) (NN production)))))
	 (PP (IN in)
	     (NP (NP (CC both)
		     (NML (NN HF-IPF) (CC and) (NN HF-NL))
		     (CODE -LRB-)
		     (PRN (NP (CD 28.35))
			  (CODE <bracket>)
			  (NP (NN range)
			      (: :)
			      (QP (CD 9.09) (SYM -) (CD 89.09)))))
		 (CODE <$$bracket>)
		 (PP (IN versus)
		     (NP (NP (QP (CD 17.12) (CODE <bracket>) (CD 8.58) (SYM -) (CD 29.33))
			     (CODE <$$bracket>)
			     (NNS ng))
			 (PP (SYM $$)
			     (NP (QP (CD 10) (CD 6))
				 (NNS cells)))
			 (PP (SYM $$)
			     (NP (CD 30) (NNS min)))))
		 (, ,)
		 (ADVP (RB respectively)))))
     (, ;)
     (S (NP-SBJ (NNP P))
	(VP (VBZ =)
	    (NP-PRD (CD 0.25))))
     (, ;)
     (CODE <bracket>)
     (REF (NP (NN Fig.) (NN 1a)))
     (CODE <$$bracket>)
     (CODE -RRB-)
     (. .)))

( (S (NP-SBJ (NP (ADJP (NN IL-1?) (HYPH -) (VBN stimulated))
		 (NN production))
	     (PP (IN of)
		 (NP (NP (NP (NN TXB) (CD 2))
			 (CODE -LRB-)
			 (NP (NP (JJ stable) (NN metabolite))
			     (PP (IN of)
				 (NP (DT the) (JJ active) (NN TXA) (CD 2)))))
		     (CODE -RRB-)
		     (, ,)
		     (NP (NN PGF) (NN 2?))
		     (, ,)
		     (CC and)
		     (NP (NP (NN 6-keto-PGF) (NN 1?))
			 (CODE -LRB-)
			 (NP (NP (JJ stable) (NN metabolite))
			     (PP (IN of)
				 (NP (NN PGI) (CD 2))))))))
     (CODE -RRB-)
     (VP (VBD increased)
	 (ADVP-MNR (RB modestly))
	 (PP (IN in)
	     (NP (NP (DT every) (NN case))
		 (PP (, ,)
		     (IN except)
		     (NP (NP (NP (NML (NN TXB) (CD 2))
				 (NN production))
			     (PP (IN by)
				 (NP (NN HF-NL))))
			 (, ,)
			 (SBAR (WHNP-1 (WP which))
			       (S (NP-SBJ (-NONE- *T*-1))
				  (VP (VBD decreased)
				      (CODE -LRB-)
				      (PRN (NP (NP (NP (EQUA (CD 0.75) (CODE <bracket>) (CD 0.15) (HYPH -) (CD 2.58) (CODE <$$bracket>) (NNS ng) (SYM $$) (CD 10) (CD 6) (NNS cells) (SYM $$) (CD 30) (NNS min)))
						   (PP (IN at)
						       (NP (NN baseline))))
					       (PP (IN versus)
						   (NP (NP (EQUA (CD 0.61) (CODE <bracket>) (CD 0.21) (SYM -) (CD 1.64) (CODE <$$bracket>) (NNS ng) (SYM $$) (CD 10) (CD 6) (NNS cells) (SYM $$) (CD 30) (NNS min)))
						       (PP (IN with)
							   (NP (NN IL-1?) (NN stimulation)))))))))))))))
     (CODE -RRB-)
     (CODE -LRB-)
     (REF (NP (NN Fig.) (NN 1b)))
     (CODE -RRB-)
     (. .)))

( (S (NP-SBJ (NP (NNS Results))
	     (PP (IN of)
		 (NP (NML (NN PGE) (CD 3))
		     (NN production))))
     (VP (VBD were)
	 (ADJP-PRD (JJ similar))
	 (SBAR-TMP (WHADVP-1 (WRB when))
		   (S (NP-SBJ-2 (NNS experiments))
		      (VP (VBD were)
			  (VP (VBN conducted)
			      (NP (-NONE- *-2))
			      (PP-LOC (IN in)
				      (NP (NML (ADJP (NN serum) (JJ free))
					       (NNS media))
					  (NNS conditions)))
			      (ADVP-TMP (-NONE- *T*-1))))))
	 (CODE -LRB-)
	 (S-ADV (NP-SBJ-3 (NNS results))
		(VP (RB not)
		    (VBN shown)
		    (NP (-NONE- *-3)))))
     (CODE -RRB-)
     (. .)))

( (S (S (NP-SBJ (ADJP (NN IL-1?) (VBN stimulated))
		(NML (NN TXB) (CD 2))
		(NN production))
	(VP (VBD was)
	    (ADJP-PRD (RB significantly) (JJR greater))
	    (PP (IN in)
		(NP (NP (NN HF-IPF)
			(CODE -LRB-)
			(PRN (EQUA (CD 1.92) (CODE <bracket>) (CD 1.27) (SYM -) (CD 2.57) (CODE <$$bracket>) (NNS ng) (SYM $$) (CD 10) (CD 6) (NNS cells) (SYM $$) (CD 30) (NNS min))))
		    (CODE -RRB-)
		    (PP (IN than)
			(PP (IN in)
			    (NP (NN HF-NL)
				(CODE -LRB-)
				(PRN (EQUA (QP (CD 0.61) (CODE <bracket>) (CD 0.21) (SYM -) (CD 1.64))
					   (CODE <$$bracket>)
					   (NNS ng)
					   (SYM $$)
					   (CD 10)
					   (CD 6)
					   (NNS cells)
					   (SYM $$)
					   (CD 30)
					   (NNS min))
				     (, ;)
				     (S (NP-SBJ (NNP P))
					(VP (VBZ =)
					    (NP-PRD (CD 0.007))))))))))))
     (CODE -RRB-)
     (CODE -LRB-)
     (REF (NP (NN Fig.) (NN 1b)))
     (CODE -RRB-)
     (, ;)
     (S (NP-SBJ (NN baseline)
		(NML (NN TXB) (CD 2))
		(NN production))
	(VP (VBD was)
	    (RB not)
	    (ADJP-PRD (RB significantly) (JJ different))
	    (PP (IN between)
		(NP (DT the) (CD two) (NN cell) (NNS groups)))
	    (CODE -LRB-)
	    (PRN (EQUA (EQUA (CD 1.73) (CODE <bracket>) (CD 0.77) (SYM -) (CD 2.53))
		       (CODE <$$bracket>)
		       (PP (IN versus)
			   (EQUA (CD 0.75) (CODE <bracket>) (CD 0.15-2.58) (CODE <$$bracket>) (NNS ng) (SYM $$) (CD 10) (CD 6) (NNS cells) (SYM $$) (CD 30) (NNS min))))
		 (, ,)
		 (PP (IN in)
		     (NP (NP (NN HF-IPF) (CC and) (NN HF-NL))
			 (, ,)
			 (ADVP (RB respectively))))
		 (, ;)
		 (S (NP-SBJ (NNP P))
		    (VP (VBZ =)
			(NP-PRD (CD 0.17)))))))
     (CODE <bracket>)
     (REF (NP (NN Fig.) (NN 1b)))
     (CODE <$$bracket>)
     (CODE -RRB-)
     (. .)))

( (S (SBAR-PRP (IN Because)
	       (S (NP-SBJ (NP (NN PGI) (CD 2))
			  (CC and)
			  (NP (NN TXA) (CD 2)))
		  (VP (VBP have)
		      (VP (VBG opposing)
			  (NP (NNS effects))
			  (NP-LOC (FW in) (FW vivo))))))
     (, ,)
     (NP-SBJ (PRP we))
     (VP (VP (VBD calculated)
	     (NP (NP (DT the) (NN ratio))
		 (PP (IN of)
		     (NP (PRP$ their) (NNS metabolites))))
	     (CODE -LRB-)
	     (PRN (XX (CD 6) (HYPH -) (NN keto) (HYPH -) (NN PGF) (NN 1?) (SYM :) (NN TXB) (CD 2))))
	 (CODE -RRB-)
	 (CC and)
	 (VP (VP (VBD found)
		 (NP (NP (DT a)
			 (ADJP (RB significantly) (JJR lower))
			 (NN ratio))
		     (PP (IN in)
			 (NP (NN HF-IPF))))
		 (PP (IN at)
		     (NP (NN baseline)))
		 (CODE -LRB-)
		 (PRN (EQUA (EQUA (CD 0.08) (CODE <bracket>) (CD 0.04) (SYM -) (CD 0.52))
			    (CODE <$$bracket>)
			    (PP (IN versus)
				(EQUA (CD 0.12) (CODE <bracket>) (CD 0.11) (SYM -) (CD 0.89))))
		      (CODE <$$bracket>)
		      (PP (IN in)
			  (NP (NP (NN HF-IPF) (CC and) (NN HF-NL))
			      (, ,)
			      (ADVP (RB respectively))))
		      (, ;)
		      (S (NP-SBJ (NN P))
			 (VP (VBZ =)
			     (NP-PRD (CD 0.028))))))
	     (CODE -RRB-)
	     (CC and)
	     (VP (NP (DT a) (JJ similar) (NN trend))
		 (PP (IN under)
		     (NP (VBN stimulated) (NNS conditions)))
		 (CODE -LRB-)
		 (PRN (EQUA (EQUA (CD 0.24) (CODE <bracket>) (CD 0.05) (SYM -) (CD 1.53))
			    (CODE <$$bracket>)
			    (PP (IN versus)
				(EQUA (CD 1.08) (CODE <bracket>) (CD 0.51) (SYM -) (CD 3.79))))
		      (CODE <$$bracket>)
		      (PP (IN in)
			  (NP (NP (NN HF-IPF) (CC and) (NN HF-NL))
			      (, ,)
			      (ADVP (RB respectively))))
		      (, ;)
		      (S (NP-SBJ (NN P))
			 (VP (VBZ =)
			     (NP-PRD (CD 0.09))))))))
     (CODE <bracket>)
     (REF (NP (NN Fig.) (CD 2)))
     (CODE <$$bracket>)
     (CODE -RRB-)
     (. .)))

( (NP (ADJP (ADJP (JJ Baseline))
	    (CC and)
	    (ADJP (VBN stimulated)))
      (NN COX-2)
      (NN expression)))

( (S (NP-SBJ (NP (JJ Western) (NN blot))
	     (PP (IN in)
		 (NP (JJ unstimulated) (NNS fibroblasts))))
     (VP (VBD showed)
	 (NP (DT no) (JJ detectable) (NN COX-2) (NN protein))
	 (PP (IN in)
	     (NP (NP (DT either) (NN group))
		 (PP (IN of)
		     (NP (NNS cells)))))
	 (, ,)
	 (SBAR-ADV (IN while)
		   (S (NP-SBJ (NN IL-1?))
		      (ADVP-MNR (RB significantly))
		      (VP (VBD induced)
			  (NP (NN COX-2))
			  (PP-EXT (IN to)
				  (NP (DT a) (JJ similar) (NN degree)))
			  (PP (IN in)
			      (NP (UCP (NN IPF) (CC and) (JJ normal))
				  (NN lung)
				  (NNS fibroblasts)))))))
     (CODE -LRB-)
     (REF (NP (NN Fig.) (CD 3)))
     (CODE -RRB-)
     (. .)))

( (S (NP-SBJ (JJ Northern) (NN blot))
     (VP (VP (VBD showed)
	     (NP=1 (JJ minimal) (NN COX-2) (NN mRNA))
	     (PP (IN in)
		 (NP (JJ unstimulated) (NNS cells))))
	 (CC and)
	 (VP (NP=1 (NP (JJ significant) (NN upregulation))
		   (PP (IN of)
		       (NP (NML (NN COX-2) (NN mRNA))
			   (NN expression))))
	     (SBAR-TMP (WHADVP-2 (WRB when))
		       (S (NP-SBJ-3 (-NONE- *PRO*))
			  (VP (VBN stimulated)
			      (NP (-NONE- *-3))
			      (PP-MNR (IN with)
				      (NP (NN IL-1?)))
			      (PP-LOC (IN in)
				      (NP (CC both) (NN HF-IPF) (CC and) (NN HF-NL)))
			      (ADVP-TMP (-NONE- *T*-2)))))))
     (CODE -LRB-)
     (REF (NP (NN Fig.) (CD 4)))
     (CODE -RRB-)
     (. .)))

( (NP (NN Discussion)))

( (S (NP-SBJ (NP (JJ Several) (NNS factors))
	     (PP (-NONE- *ICH*-1)))
     (VP (VBP modulate)
	 (NP (NP (NN fibroblast) (NN proliferation))
	     (CC and)
	     (NP (NN collagen) (NN production)))
	 (, ,)
	 (PP-1 (VBG including)
	       (NP (NP (JJ mitogenic)
		       (NNS cytokines)
		       (CODE -LRB-)
		       (PRN (FW e.g.)
			    (, ,)
			    (NP (VBG transforming)
				(NML (NML (NN growth)
					  (NN factor)
					  (NN ?)
					  (CODE <bracket>)
					  (PRN (NP (NN TGF?))))
				     (CODE <$$bracket>)
				     (, ,)
				     (NML (ADJP (NN platelet) (HYPH -) (VBN derived))
					  (NN growth)
					  (NN factor)
					  (CODE <bracket>)
					  (PRN (NP (NN PDGF))))
				     (CODE <$$bracket>)
				     (, ,)
				     (NML (JJ basic)
					  (NN fibroblast)
					  (NN growth)
					  (NN factor)
					  (CODE <bracket>)
					  (PRN (NP (NN bFGF))))))))
		   (CODE <$$bracket>)
		   (CODE -RRB-)
		   (, ,)
		   (NP (NNS eicosanoids)
		       (CODE -LRB-)
		       (PRN (FW i.e.)
			    (, ,)
			    (NP (NP (NN PGE) (CD 2))
				(NP (, ,) (NN TXB) (CD 2))
				(, ,)
				(CC and)
				(NP (NN PGI) (CD 2)))))
		   (CODE -RRB-)
		   (, ,)
		   (CC and)
		   (NP (JJ antifibrogenic)
		       (NNS cytokines)
		       (CODE -LRB-)
		       (PRN (FW e.g.)
			    (NP (NN IFN-?)))))))
     (CODE -RRB-)
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (S (NP-SBJ (NP (PRP It))
		(SBAR (-NONE- *EXP*-1)))
	(VP (VBZ is)
	    (ADJP-PRD (RB very) (JJ likely))
	    (SBAR-1 (IN that)
		    (S (NP-SBJ (NP (DT a) (JJ complex) (NN interaction))
			       (PP (IN among)
				   (NP (DT these) (NNS factors))))
		       (VP (VBZ exists)
			   (PP (IN in)
			       (NP (DT the)
				   (NML (NN tissue) (NN repair))
				   (NN process))))))))
     (, ,)
     (CC and)
     (S (NP-SBJ (NP (PRP it))
		(SBAR (-NONE- *EXP*-2)))
	(VP (VBZ is)
	    (ADJP-PRD (JJ possible))
	    (SBAR-2 (IN that)
		    (S (NP-SBJ (NP (JJ pathologic) (NN fibrosis))
			       (, ,)
			       (PP (IN as)
				   (PP (IN in)
				       (NP (NN IPF)))))
		       (, ,)
		       (VP (VBZ results)
			   (PP-CLR (IN from)
				   (NP (NP (NP (JJ phenotypical) (NNS alterations))
					   (PP (IN in)
					       (NP (NNS fibroblasts))))
				       (SBAR (WHNP-3 (WDT that))
					     (S (NP-SBJ (-NONE- *T*-3))
						(VP (VBP affect)
						    (NP (NP (DT the) (" ") (JJ normal) (" ") (NN interaction))
							(PP (IN of)
							    (NP (DT these) (NNS factors))))))))))))))
     (. .)))

( (S (NP-SBJ (PRP$ Our) (NNS results))
     (VP (VBP show)
	 (SBAR (IN that)
	       (S (NP-SBJ (NP (NN stimulation))
			  (PP (IN of)
			      (NP (NP (JJ primary) (NNS cultures))
				  (PP (IN of)
				      (NP (NML (JJ human) (NN lung))
					  (NNS fibroblasts)))))
			  (PP (IN with)
			      (NP (NP (DT the) (JJ proximal) (NN cytokine))
				  (NP (NN IL-1?)))))
		  (VP (VBZ upregulates)
		      (NP (NP (NN COX-2) (NN protein))
			  (CC and)
			  (NP (NN mRNA) (NN expression)))
		      (PP-EXT (IN to)
			      (NP (DT a) (JJ similar) (NN degree)))
		      (PP (IN in)
			  (NP (UCP (JJ normal) (CC and) (NN IPF))
			      (NNS fibroblasts)))))))
     (. .)))

( (S (S (NP-SBJ-1 (NML (NN TXA) (CD 2))
		  (NN production))
	(VP (VBD tended)
	    (S (NP-SBJ (-NONE- *-1))
	       (VP (TO to)
		   (VP (VB be)
		       (ADJP-PRD (ADJP (JJR greater))
				 (PP (-NONE- *ICH*-2)))
		       (PP (IN in)
			   (NP (NN IPF)))
		       (PP-2 (IN than)
			     (PP (IN in)
				 (NP (NP (JJ normal) (NNS fibroblasts))
				     (PP (IN at)
					 (NP (NN baseline)))))))))))
     (, ;)
     (S (SBAR-TMP (WHADVP-3 (WRB when))
		  (S (NP-SBJ-4 (-NONE- *PRO*))
		     (VP (VBN stimulated)
			 (NP (-NONE- *-4))
			 (PP-MNR (IN with)
				 (NP (NN IL-1?)))
			 (ADVP-TMP (-NONE- *T*-3)))))
	(NP-SBJ (DT this) (NN difference))
	(VP (VBD became)
	    (ADJP-PRD (RB statistically) (JJ significant))))
     (. .)))

( (S (NP-SBJ (NP (DT The) (NN ratio))
	     (PP (IN of)
		 (NP (NP (NN PGI) (CD 2))
		     (PP (IN to)
			 (NP (NML (NN TXA) (CD 2))
			     (NNS metabolites))))))
     (VP (VBD was)
	 (ADJP-PRD (JJR lower))
	 (PP (IN in)
	     (NP (NN IPF) (NNS fibroblasts)))
	 (PP (PP (IN at)
		 (NP (NN baseline)))
	     (CC and)
	     (PP (IN with)
		 (NP (NN IL-1?) (NN stimulation)))))
     (. .)))

( (S (NP-SBJ (DT The) (RB above) (NNS results))
     (VP (VBP suggest)
	 (SBAR (IN that)
	       (S (NP-SBJ (DT a)
			  (VBN decreased)
			  (NML (NML (NN PGI) (CD 2))
			       (SYM :)
			       (NML (NN TXA) (CD 2)))
			  (NN ratio))
		  (VP (MD could)
		      (VP (VB be)
			  (NP-PRD (NP (DT a) (JJ phenotypic) (NN alteration))
				  (RRC (ADJP (JJ present))
				       (PP (IN in)
					   (NP (NN IPF) (NNS fibroblasts))))
				  (, ,)
				  (VP (VBG resulting)
				      (PP-CLR (IN in)
					      (NP (NP (DT a) (NN loss))
						  (PP (IN of)
						      (NP (NP (PRP$ their) (NN capacity))
							  (S (NP-SBJ (-NONE- *PRO*))
							     (VP (TO to)
								 (VP (VB autoregulate)
								     (NP (NP (NN proliferation))
									 (CC and)
									 (NP (JJ extracellular) (NN matrix) (NN production)))))))))))))))))
     (. .)))

( (S (NP-SBJ-1 (NP (DT The) (NNS effects))
	       (PP (IN of)
		   (NP (NNS PGs)))
	       (PP (IN on)
		   (NP (NP (NN cell) (NN proliferation))
		       (CC and)
		       (NP (NN collagen) (NN production)))))
     (VP (VBP have)
	 (VP (VBN been)
	     (ADVP (RB widely))
	     (VP (VBN studied)
		 (NP (-NONE- *-1))
		 (PP-LOC (IN in)
			 (NP (JJ different) (NN cell) (NNS types))))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (NP-SBJ-1 (NN TXA) (CD 2))
     (VP (VBZ has)
	 (VP (VBN been)
	     (VP (VBN studied)
		 (NP (-NONE- *-1))
		 (ADVP-MNR (RB extensively))
		 (PP-PRP (IN because)
			 (IN of)
			 (NP (NP (PRP$ its) (JJ apparent) (NN role))
			     (PP (IN in)
				 (NP (NN atherosclerosis)))))
		 (, ,)
		 (PP-PRP (JJ due)
			 (IN to)
			 (NP (NP (PRP$ its)
				 (ADJP (JJ prothrombotic) (CC and) (JJ mitogenic))
				 (NNS activities))
			     (PP (IN on)
				 (NP (JJ vascular)
				     (NML (JJ smooth) (NN muscle))
				     (NNS cells))))))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (NP-SBJ-1 (DT These) (JJ mitogenic) (NNS effects))
     (VP (VBP are)
	 (VP (VBN potentiated)
	     (NP (-NONE- *-1))
	     (PP (IN by)
		 (NP-LGS (NN growth) (NNS factors)))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (PP-LOC (IN In)
	     (NP (JJ vascular)
		 (NML (JJ smooth) (NN muscle))
		 (NNS cells)))
     (NP-SBJ (NN TXA) (CD 2))
     (VP (VP (VBZ stimulates)
	     (NP (NP (NN synthesis))
		 (PP (IN of)
		     (NP (NN bFGF)))))
	 (CC and)
	 (VP (VBZ increases)
	     (NP (NP (DT the) (NN expression))
		 (PP (IN of)
		     (NP (NP (NP (DT the) (NNS proto-oncogenes))
			     (NP (NN c-fos) (, ,) (NN c-myc) (, ,) (CC and) (NN egr-1)))
			 (, ,)
			 (SBAR (WHNP-1 (WP which))
			       (S (NP-SBJ-2 (-NONE- *T*-1))
				  (VP (VBP are)
				      (VP (VBN associated)
					  (NP (-NONE- *-2))
					  (PP-CLR (IN with)
						  (NP (NP (NN entry))
						      (PP (IN into)
							  (NP (DT the)
							      (NML (NN cell) (NN growth))
							      (NN cycle))))))))))))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (PP (IN In)
	 (NP (NN addition)))
     (, ,)
     (NP-SBJ (NN TXA) (CD 2))
     (VP (VBZ increases)
	 (NP (NP (NN proliferation))
	     (PP (IN of)
		 (NP (NP (NNS fibroblasts))
		     (CODE {COM:footnote_indexicals_omitted})
		     (CC and)
		     (NP (JJ smooth) (JJ muscle-like) (JJ glomerular) (JJ mesangial) (NNS cells))))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (PP (IN On)
	 (NP (DT the) (JJ other) (NN hand)))
     (, ,)
     (NP-SBJ (NN PGI) (CD 2))
     (VP (VBZ decreases)
	 (NP (NP (JJ vascular)
		 (NML (JJ smooth) (NN muscle))
		 (NN cell)
		 (NN proliferation))
	     (CC and)
	     (NP (NML (NN collagen) (CC and) (NN glycosaminoglycane))
		 (NN synthesis)))
	 (, ,)
	 (PP-MNR (IN via)
		 (NP (NP (NP (NN activation))
			 (PP (IN of)
			     (NP (NN adenylyl) (NN cyclase))))
		     (CC and)
		     (NP (NP (JJ subsequent) (NN production))
			 (PP (IN of)
			     (NP (NN cAMP)))))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (NP-SBJ (NP (NN Betaprost))
	     (, ,)
	     (NP (NP (DT an) (NN analog))
		 (PP (IN of)
		     (NP (NN PGI) (CD 2)))))
     (, ,)
     (VP (VBZ decreases)
	 (NP (NML (NN procollagen)
		  (NML (CD I) (CC and) (CD III)))
	     (NN mRNA)
	     (NN expression))
	 (PP (IN in)
	     (NP (JJ cardiac) (NNS fibroblasts))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (S (NP-SBJ (DT These) (NNS effects))
	(VP (MD may)
	    (VP (VB counteract)
		(NP (NP (DT the) (JJ profibrotic) (NNS effects))
		    (VP (VBN seen)
			(NP (-NONE- *))
			(PP (IN with)
			    (NP (NN TXA) (CD 2))))))))
     (CC and)
     (S (NP-SBJ (NP (PRP it))
		(SBAR (-NONE- *EXP*-1)))
	(VP (VBZ is)
	    (ADJP-PRD (JJ possible))
	    (SBAR-1 (IN that)
		    (S (NP-SBJ (NP (DT an) (NN alteration))
			       (PP (IN of)
				   (NP (NP (DT a) (" ") (JJ normal) (" ") (JJ physiologic) (NN balance))
				       (PP (IN between)
					   (NP (NP (NN PGI) (CD 2))
					       (CC and)
					       (NP (NN TXA) (CD 2)))))))
		       (VP (MD could)
			   (VP (VB increase)
			       (NP (NP (NN tendency))
				   (PP (IN towards)
				       (NP (NN fibrogenesis))))))))))
     (. .)))

( (S (NP-SBJ (NP (PRP It))
	     (S (-NONE- *EXP*-1)))
     (VP (VBZ is)
	 (ADJP-PRD (JJ important))
	 (S-1 (NP-SBJ (-NONE- *PRO*))
	      (VP (TO to)
		  (VP (VB mention)
		      (SBAR (IN that)
			    (S (NP-SBJ-2 (PRP$ our) (NNS experiments))
			       (VP (VBD were)
				   (VP (VBN conducted)
				       (NP (-NONE- *-2))
				       (PP (IN at)
					   (NP (NP (JJ similar) (NN passage) (NNS levels))
					       (CODE -LRB-)
					       (NP (NN passage)
						   (QP (CD 6) (IN to) (CD 8)))))
				       (PP (CODE -RRB-)
					   (IN in)
					   (NP (DT both) (NNS groups))))))))))
	 (, ,)
	 (SBAR-PRP (IN since)
		   (S (NP-SBJ-3 (NP (NN senescence))
				(PP (IN of)
				    (NP (NNS fibroblasts))))
		      (VP (VBZ is)
			  (VP (VBN associated)
			      (NP (-NONE- *-3))
			      (PP-CLR (IN with)
				      (NP (NP (DT a) (NN shift))
					  (PP (IN from)
					      (NP (NP (DT the) (NN biosynthesis))
						  (PP (IN of)
						      (NP (NN PGI) (CD 2)))))
					  (PP (IN to)
					      (NP (NN TXA)
						  (QP (CD 2)))))))))))
     (CODE {COM:footnote_indexicals_omitted})
     (. .)))

( (S (NP-SBJ (NP (PRP It))
	     (SBAR (-NONE- *EXP*-1)))
     (VP (VBZ is)
	 (ADJP-PRD (JJ possible))
	 (SBAR-1 (IN that)
		 (S (NP-SBJ (NP (DT the) (NN difference))
			    (VP (VBN seen)
				(NP (-NONE- *))
				(PP (IN in)
				    (NP (PRP$ our) (NN study))))
			    (PP (IN between)
				(NP (NN HF-IPF) (CC and) (NN HF-NL))))
		    (VP (MD could)
			(VP (VB result)
			    (PP-CLR (IN from)
				    (S-NOM (NP-SBJ (-NONE- *PRO*))
					   (VP (VBG comparing)
					       (NP (NP (NNS fibroblasts))
						   (PP (IN of)
						       (NP (JJ different) (NNS ages))))))))))))
     (. .)))

( (S (NP-SBJ-1 (NN HF-IPF))
     (VP (MD might)
	 (VP (VB have)
	     (VP (VBN been)
		 (VP (VBN harvested)
		     (NP (-NONE- *-1))
		     (PP (IN from)
			 (NP (NP (JJ fibrotic) (NNS lesions))
			     (SBAR (WHADVP-2 (WRB where))
				   (S (NP-SBJ (NNS fibroblasts))
				      (VP (VBD had)
					  (ADVP-TMP (RB previously))
					  (VP (VBN undergone)
					      (NP (NP (DT a) (JJR greater) (NN number))
						  (PP (IN of)
						      (NP (NN cell) (NNS divisions)))
						  (PP (IN than)
						      (NP (NP (NN HF-NL))
							  (, ,)
							  (VP (VBN obtained)
							      (NP (-NONE- *))
							      (PP (IN from)
								  (NP (JJ nonfibrotic) (NNS lungs)))))))
					      (ADVP-LOC (-NONE- *T*-2))))))))))))
     (. .)))

( (S (SBAR-ADV (IN Although)
	       (S (NP-SBJ (DT this))
		  (VP (VBZ is)
		      (NP-PRD (DT a) (NN possibility)))))
     (, ,)
     (NP-SBJ-1 (NP (DT the)
		   (ADJP (NN age) (HYPH -) (VBN related))
		   (NN shift))
	       (PP (IN in)
		   (NP (NN PG) (NN production))))
     (VP (VP (VBZ has)
	     (ADVP (RB only))
	     (VP (VBN been)
		 (VP (VBN shown)
		     (NP (-NONE- *-1))
		     (PP-LOC (IN at)
			     (NP (ADJP (RB very) (JJ high))
				 (NN cell)
				 (NNS passages))))))
	 (CC and)
	 (VP (VBZ has)
	     (RB not)
	     (VP (VBN been)
		 (VP (VBN documented)
		     (NP (-NONE- *-1))
		     (ADVP-LOC (FW in) (FW vivo))))))
     (. .)))

( (S (NP-SBJ (PRP We))
     (ADVP (RB also))
     (VP (VBD found)
	 (SBAR (IN that)
	       (S (NP-SBJ (CC both) (NN HF-IPF) (CC and) (NN HF-NL))
		  (VP (VP (VBD had)
			  (NP=1 (JJ similar)
				(NML (NN PGE) (CD 2))
				(NN production))
			  (PP=2 (IN at)
				(NP (NN baseline))))
		      (, ,)
		      (CC and)
		      (VP (NP=1 (DT a) (JJ similar) (NN increase))
			  (SBAR-TMP=2 (WHADVP-3 (WRB when))
				      (S (NP-SBJ-4 (-NONE- *PRO*))
					 (VP (VBN stimulated)
					     (NP (-NONE- *-4))
					     (PP-MNR (IN with)
						     (NP (NN IL-1?)))
					     (ADVP-TMP (-NONE- *T*-3))))))))))
     (. .)))

( (S (NP-SBJ (NN PGE) (CD 2))
     (VP (MD can)
	 (VP (VP (VB decrease)
		 (NP (NP (NN fibroblast) (NN proliferation))
		     (CC and)
		     (NP (NN collagen) (NN synthesis))))
	     (, ,)
	     (CC and)
	     (VP (VB increase)
		 (NP (NN collagen) (NN degradation)))))
     (CODE {COM:footnote_indexical_omitted})
     (. .)))

( (S (NP-SBJ (NP (JJ Recent) (NNS reports))
	     (VP (VBG suggesting)
		 (NP (NP (VBN decreased)
			 (NML (NML (NN COX-2) (NN expression))
			      (CC and)
			      (NML (NN PGE) (CD 2)))
			 (NN production))
		     (PP (IN in)
			 (NP (NN IPF) (NNS fibroblasts))))))
     (VP (VBP have)
	 (VP (VBN received)
	     (NP (JJ significant)
		 (NN attention)
		 (QP (CODE <bracket>) (CD 12) (CD 20) (CD 21)))))
     (CODE <$$bracket>)
     (. .)))

( (S (PP (IN In)
	 (NP (PRP$ our) (NN study)))
     (NP-SBJ (PRP we))
     (VP (VBD found)
	 (SBAR (IN that)
	       (S (NP-SBJ-1 (CC both)
			    (NP (NML (NN COX-2) (NN protein))
				(NN expression))
			    (CC and)
			    (NP (NML (NN PGE) (CD 2))
				(NN production)))
		  (VP (VBD were)
		      (VP (VBN upregulated)
			  (NP (-NONE- *-1))
			  (PP-EXT (IN to)
				  (NP (DT a) (JJ similar) (NN degree)))
			  (PP (IN in)
			      (NP (UCP (NN IPF) (CC and) (JJ normal))
				  (NN lung)
				  (NNS fibroblasts))))))))
     (. .)))

( (S (NP-SBJ (PRP We))
     (VP (VBP believe)
	 (SBAR (IN that)
	       (S (NP-SBJ (NP (NNS differences))
			  (PP (IN in)
			      (NP (NP (NN methodology))
				  (CC and)
				  (NP (NN patient) (NN selection)))))
		  (VP (MD may)
		      (VP (VB explain)
			  (NP (NP (DT the) (NNS discrepancies))
			      (PP (IN with)
				  (NP (JJ other) (NNS studies)))))))))
     (. .)))

( (S (NP-SBJ (NNP Vancheri) (CC and) (NNS collaborators))
     (CODE {COM:footnote_indexicals_omitted})
     (VP (VBD found)
	 (SBAR (IN that)
	       (S (NP-SBJ (ADJP (NN TNF-?) (HYPH -) (VBN stimulated))
			  (JJ fibrotic)
			  (NN lung)
			  (NNS fibroblasts))
		  (VP (VBD had)
		      (NP (VBN decreased)
			  (NML (NML (NN COX-2) (NN expression))
			       (CC and)
			       (NML (NML (NN PGE) (CD 2))
				    (NN production))))))))
     (, ,)
     (CC but)
     (S (NP-SBJ (PRP they))
	(ADVP (RBR further))
	(VP (VBD showed)
	    (SBAR (IN that)
		  (S (NP-SBJ (DT these) (NNS findings))
		     (VP (VBD were)
			 (NP-PRD (NP (DT a) (NN result))
				 (PP (IN of)
				     (NP (NP (VBN decreased) (NN expression))
					 (PP (IN of)
					     (NP (NN TNF-?) (NNS receptors)))))))))))
     (. .)))

( (S (NP-SBJ (DT The) (JJ latter) (NN finding))
     (VP (MD would)
	 (VP (VB argue)
	     (PP-CLR (IN against)
		     (NP (NP (DT a) (JJ primary) (NN defect))
			 (PP (IN in)
			     (NP (NN COX-2) (NN expression)))))
	     (, ,)
	     (SBAR-PRP (IN since)
		       (S (NP-SBJ-1 (NP (DT no) (JJ other) (NN stimulus))
				    (, ,)
				    (ADJP (ADJP (JJ other))
					  (PP (IN than)
					      (NP (NN TNF-?)))))
			  (, ,)
			  (VP (VBD was)
			      (VP (VBN tested)
				  (NP (-NONE- *-1))))))))
     (. .)))

( (S (PP (IN In)
	 (NP (DT another) (NN study)))
     (, ,)
     (NP-SBJ (NNP Keerthisingam) (FW et) (FW al.))
     (CODE {COM:footnote_indexical_omitted})
     (VP (VBD reported)
	 (SBAR (IN that)
	       (S (NP-SBJ (JJ fibrotic) (NN lung) (NNS fibroblasts))
		  (VP (VBD had)
		      (VP (VBN decreased)
			  (NP (NP (NN COX-2) (NN expression))
			      (CC and)
			      (NP (NML (NN PGE) (CD 2))
				  (NN production)))
			  (PP (IN in)
			      (NP (NP (NN response))
				  (PP (IN to)
				      (NP (NN TGF?) (NN stimulation))))))))))
     (. .)))

( (S (NP-SBJ (DT This) (NN study))
     (VP (VBD differed)
	 (PP (IN from)
	     (NP (PRP ours)))
	 (PP (IN in)
	     (SBAR-NOM (IN that)
		       (S (NP-SBJ-1 (DT a) (JJ different) (NN stimulus))
			  (VP (VBD was)
			      (VP (VBN used)
				  (NP (-NONE- *-1))))))))
     (. .)))

( (SINV (PP-PRD-TPC-1 (IN Of)
		      (NP (NN significance)))
	(VP (VBZ is)
	    (PP-PRD (-NONE- *T*-1)))
	(NP-SBJ (NP (DT the) (NN fact))
		(SBAR (IN that)
		      (S (S (NP-SBJ-2 (DT the) (NN COX-2) (NN gene))
			    (VP (VBZ is)
				(VP (VBN known)
				    (S (NP-SBJ (-NONE- *-2))
				       (VP (TO to)
					   (VP (VB be)
					       (ADJP-PRD (NN NF-?B) (JJ dependent))))))))
			 (, ,)
			 (CC and)
			 (S (NP-SBJ (NP (NN IL-1?))
				    (, ,)
				    (CONJP (CC but) (RB not))
				    (NP (NN TGF?)))
			    (, ,)
			    (VP (VBZ is)
				(NP-PRD (NP (DT a) (JJ potent) (NN inducer))
					(PP (IN of)
					    (NP (NN NF-?B) (NN activation)))))))))
	(. .)))

( (S (ADVP (RB Hence))
     (, ,)
     (NP-SBJ (NP (DT the) (NN pathway))
	     (VP (VBN involved)
		 (NP (-NONE- *))
		 (PP-CLR (IN in)
			 (NP (NP (DT the) (NN induction))
			     (PP (IN of)
				 (NP (DT the) (NN COX-2) (NN gene)))
			     (PP (IN by)
				 (NP (NN IL-1?) (CC and) (NN TGF?)))))))
     (VP (MD may)
	 (VP (VB be)
	     (ADJP-PRD (JJ different))))
     (. .)))

( (S (ADVP (RB Furthermore))
     (, ,)
     (NP-SBJ-1 (NP (DT a) (JJ significant) (NN proportion))
	       (PP (IN of)
		   (NP (NP (DT the) (NNS fibroblasts))
		       (VP (VBN used)
			   (NP (-NONE- *))
			   (PP (IN in)
			       (NP (DT the) (NN study)))
			   (PP (IN by)
			       (NP-LGS (NNP Keerthisingam) (FW et) (FW al.)))))))
     (CODE {COM:footnote_indexicals_omitted})
     (VP (VBD were)
	 (VP (VBN obtained)
	     (NP (-NONE- *-1))
	     (PP (IN from)
		 (NP (NP (NNS patients))
		     (PP (IN with)
			 (NP (NP (JJ systemic) (NN sclerosis))
			     (, ,)
			     (SBAR (WHNP-2 (WP which))
				   (S (NP-SBJ (-NONE- *T*-2))
				      (VP (VBZ makes)
					  (S (NP-SBJ (PRP$ their) (NN fibroblast) (NN population))
					     (ADJP-PRD (RBR more) (JJ heterogeneous))))))))))))
     (. .)))

( (S (NP-SBJ (NNP Wilborn) (FW et) (FW al.))
     (CODE {COM:footnote_indexical_omitted})
     (ADVP (RB also))
     (VP (VBD reported)
	 (NP (NP (DT a) (VBN decreased) (NN production))
	     (PP (IN of)
		 (NP (NN PGE) (CD 2)))
	     (PP (IN by)
		 (NP (ADJP (NN IL-1?) (HYPH -) (VBN stimulated))
		     (NN IPF)
		     (NNS fibroblasts))))
	 (, ,)
	 (PP-PRP (IN due)
		 (IN to)
		 (NP (VBN decreased) (NN COX-2) (NN expression))))
     (CODE <bracket>)
     (CD 12)
     (CODE <$$bracket>)
     (. .)))

( (S (NP-SBJ (EX There))
     (VP (VBZ is)
	 (NP-PRD (NP (DT a) (NN possibility))
		 (SBAR (IN that)
		       (S (NP-SBJ (NN patient) (NN selection))
			  (VP (MD may)
			      (VP (VB have)
				  (VP (VBN differed)
				      (PP (IN between)
					  (NP (DT the) (CD two) (NNS studies))))))))))
     (. .)))

( (S (ADVP (RB However))
     (, ,)
     (NP-SBJ (PRP we))
     (VP (VBP feel)
	 (ADJP-PRD (ADJP (JJ certain))
		   (SBAR (IN that)
			 (S (NP-SBJ (NP (DT the) (JJ diagnostic) (NN accuracy))
				    (PP (IN of)
					(NP (PRP$ our) (NN patient) (NN population))))
			    (VP (VBD was)
				(ADJP-PRD (JJ high))
				(, ,)
				(PP-PRP (IN due)
					(PP (IN to)
					    (NP (NP (DT the) (NN fact))
						(SBAR (IN that)
						      (S (NP-SBJ (NP (QP (NP (NP (CD 5))
									     (PP (IN out)
										 (PP (IN of)
										     (NP (NP (DT a) (NN total))
											 (PP (IN of)
											     (NP (CD 7))))))))
								     (NN IPF)
								     (NNS subjects))
								 (VP (VBN included)
								     (NP (-NONE- *))
								     (PP (IN in)
									 (NP (PRP$ our) (NN study)))))
							 (VP (VBD underwent)
							     (NP (NN lung) (NN transplantation))
							     (PP (IN with)
								 (S-NOM (NP-SBJ (JJ confirmatory) (NN pathology) (NNS results))
									(ADJP-PRD (ADJP (JJ consistent))
										  (PP (IN with)
										      (NP (NN IPF)))))))))))))))))
     (. .)))

( (S (NP-SBJ (DT The) (JJ other) (CD 2) (NNS subjects))
     (VP (VBD had)
	 (NP (ADJP (NN biopsy) (HYPH -) (VBN proven))
	     (NN IPF)))
     (. .)))

( (S (PP (IN In)
	 (NP (NN addition)))
     (, ,)
     (NP-SBJ (PRP$ our) (NNS results))
     (VP (VBD were)
	 (ADJP-PRD (JJ similar))
	 (SBAR-TMP (WHADVP-1 (WRB when))
		   (S (NP-SBJ (-NONE- *PRO*))
		      (VP (VBG comparing)
			  (NP (NP (NN lung) (NNS fibroblasts))
			      (VP (VBN obtained)
				  (NP (-NONE- *))
				  (PP (IN from)
				      (NP (NP (CD 5) (NNS subjects))
					  (PP (IN with)
					      (NP (NML (JJ advanced) (NN stage))
						  (NN IPF)))))
				  (PP (IN with)
				      (NP (NP (DT those))
					  (PP (IN of)
					      (NP (NP (NP (CD 1) (NNS subjects))
						      (PP (IN at)
							  (NP (NP (DT an) (JJR earlier) (NN stage))
							      (PP (IN of)
								  (NP (PRP$ their) (NN disease))))))
						  (, ,)
						  (SBAR (WHNP-2 (WP who))
							(S (NP-SBJ (-NONE- *T*-2))
							   (VP (VBD had)
							       (VP (VBN received)
								   (NP (DT no) (NN therapy))))))))))
				  (ADVP-TMP (-NONE- *T*-1))))))))
     (. .)))

( (S (SBAR-ADV (IN Although)
	       (S (NP-SBJ (NP (DT the) (NNS reasons))
			  (PP (IN for)
			      (NP (PRP$ our) (JJ different) (NNS results))))
		  (VP (VBP are)
		      (ADJP-PRD (JJ unclear)))))
     (, ,)
     (NP-SBJ (NP (DT the) (NN fact))
	     (SBAR (IN that)
		   (S (NP-SBJ (PRP we))
		      (VP (VBD found)
			  (NP (JJ similar)
			      (NML (NML (NN COX-2) (NN expression))
				   (CC and)
				   (NML (NN PGE) (CD 2)))
			      (NN production))
			  (PP (IN in)
			      (NP (UCP (JJ normal) (CC and) (NN IPF))
				  (NN lung)
				  (NNS fibroblasts)))))))
     (VP (VBZ suggests)
	 (SBAR (IN that)
	       (S (NP-SBJ (NP (NN loss))
			  (PP (IN of)
			      (NP (NN COX-2) (NN expression))))
		  (VP (VBZ is)
		      (RB not)
		      (NP-PRD (NP (DT a) (JJ universal) (NN characteristic))
			      (PP (IN of)
				  (NP (NP (NNS fibroblasts))
				      (VP (VBN cultured)
					  (NP (-NONE- *))
					  (PP (IN from)
					      (NP (NP (DT the) (NNS lungs))
						  (PP (IN of)
						      (NP (NP (NNS subjects))
							  (PP (IN with)
							      (NP (NN IPF)))))))))))))))
     (. .)))

( (NP (NN Conclusion)))

( (S (NP-SBJ (PRP We))
     (VP (VBP have)
	 (VP (VBN found)
	     (SBAR (SBAR (IN that)
			 (S (NP-SBJ (NP (NNS fibroblasts))
				    (VP (VBN cultured)
					(NP (-NONE- *))
					(PP (IN from)
					    (NP (UCP (JJ normal) (CC and) (NN IPF))
						(JJ human)
						(NNS lungs)))))
			    (VP (VBP have)
				(NP (NP (DT a)
					(ADJP (JJ significant) (CC and) (JJ similar))
					(NN induction))
				    (PP (IN of)
					(NP (DT the) (NN COX-1) (NN enzyme))))
				(SBAR-TMP (WHADVP-1 (WRB when))
					  (S (NP-SBJ-2 (-NONE- *PRO*))
					     (VP (VBN stimulated)
						 (NP (-NONE- *-2))
						 (PP-MNR (IN with)
							 (NP (NN IL-1?)))
						 (ADVP-TMP (-NONE- *T*-1))))))))
		   (, ,)
		   (CC but)
		   (SBAR (IN that)
			 (S (NP-SBJ (NN IPF) (NNS fibroblasts))
			    (VP (VP (VBD produced)
				    (NP (JJR more) (NN thromboxane)))
				(CC and)
				(VP (VBD had)
				    (NP (DT a)
					(ADJP (RB significantly) (JJR lower))
					(NML (NN prostacyclin) (SYM :) (NN thromboxane))
					(NN ratio)))))))))
     (. .)))

( (S (NP-SBJ (PRP We))
     (VP (VBP hypothesize)
	 (SBAR (IN that)
	       (S (NP-SBJ (NP (DT the)
			      (JJR lower)
			      (NML (NML (NN PGI) (CD 2))
				   (SYM :)
				   (NML (NN TXA) (CD 2)))
			      (NN ratio))
			  (VP (VBN seen)
			      (NP (-NONE- *))
			      (PP (IN in)
				  (NP (NN HF-IPF)))))
		  (VP (MD may)
		      (VP (VB be)
			  (NP-PRD (NP (DT a) (JJ phenotypic) (NN alteration))
				  (SBAR (WHNP-1 (WDT that))
					(S (NP-SBJ (-NONE- *T*-1))
					   (VP (VBZ plays)
					       (NP-CLR (DT a) (NN role))
					       (PP-CLR (IN in)
						       (NP (NP (DT the) (NN pathogenesis))
							   (PP (IN of)
							       (NP (NN IPF))))))))))))))
     (. .)))

( (NP (NNS Abbreviations)))

( (CODE {COM:list_omitted}))

